Form 20-F ☒
|
Form 40-F ☐
|
Yes ☐
|
No ☒
|
EXFO INC.
|
|
By: /s/ Germain Lamonde
Name: Germain Lamonde
Title: President and Chief Executive Officer
|
|
Re: |
Filing of Amended Annual Report for Fiscal 2016
|
As at August 31,
|
||||||||
2016
|
2015
|
|||||||
Assets
|
||||||||
Current assets
|
||||||||
Cash
|
$
|
43,208
|
$
|
25,864
|
||||
Short-term investments (note 5)
|
4,087
|
1,487
|
||||||
Accounts receivable (note 5)
|
||||||||
Trade
|
42,993
|
45,985
|
||||||
Other
|
2,474
|
2,384
|
||||||
Income taxes and tax credits recoverable (note 18)
|
4,208
|
3,855
|
||||||
Inventories (note 6)
|
33,004
|
27,951
|
||||||
Prepaid expenses
|
3,099
|
2,801
|
||||||
133,073
|
110,327
|
|||||||
Tax credits recoverable (note 18)
|
34,594
|
35,625
|
||||||
Property, plant and equipment (notes 7 and 20)
|
35,978
|
35,695
|
||||||
Intangible assets (notes 8 and 20)
|
3,391
|
4,096
|
||||||
Goodwill (notes 8 and 20)
|
21,928
|
21,860
|
||||||
Deferred income tax assets (note 18)
|
8,240
|
9,459
|
||||||
Other assets
|
589
|
416
|
||||||
$
|
237,793
|
$
|
217,478
|
|||||
Liabilities
|
||||||||
Current liabilities
|
||||||||
Accounts payable and accrued liabilities (note 10)
|
$
|
37,174
|
$
|
34,126
|
||||
Provisions
|
299
|
427
|
||||||
Income taxes payable
|
971
|
779
|
||||||
Deferred revenue
|
9,486
|
7,647
|
||||||
47,930
|
42,979
|
|||||||
Deferred revenue
|
5,530
|
2,957
|
||||||
Deferred income tax liabilities (note 18)
|
2,857
|
1,524
|
||||||
Other liabilities
|
75
|
791
|
||||||
56,392
|
48,251
|
|||||||
Commitments (note 11)
|
||||||||
Shareholders' equity
|
||||||||
Share capital (note 12)
|
85,516
|
86,045
|
||||||
Contributed surplus
|
18,150
|
17,778
|
||||||
Retained earnings
|
126,309
|
117,409
|
||||||
Accumulated other comprehensive loss (note 13)
|
(48,574
|
)
|
(52,005
|
)
|
||||
181,401
|
169,227
|
|||||||
$
|
237,793
|
$
|
217,478
|
On behalf of the Board
|
|
/s/ Germain Lamonde
|
/s/ Claude Séguin
|
Germain Lamonde
|
Claude Séguin
|
Chairman, President and CEO
|
Chairman, Audit Committee
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Sales (note 20)
|
$
|
232,583
|
$
|
222,089
|
$
|
230,806
|
||||||
Cost of sales (1) (note 16)
|
87,066
|
85,039
|
86,836
|
|||||||||
Selling and administrative (2) (note 16)
|
82,169
|
82,200
|
86,429
|
|||||||||
Net research and development (note 16)
|
42,687
|
44,003
|
44,846
|
|||||||||
Depreciation of property, plant and equipment (note 16)
|
3,814
|
4,835
|
4,995
|
|||||||||
Amortization of intangible assets (note 16)
|
1,172
|
2,883
|
4,398
|
|||||||||
Interest and other income
|
(828
|
)
|
(155
|
)
|
(326
|
)
|
||||||
Foreign exchange gain
|
(161
|
)
|
(7,212
|
)
|
(1,634
|
)
|
||||||
Unusual charge (note 1)
|
–
|
603
|
720
|
|||||||||
Earnings before income taxes
|
16,664
|
9,893
|
4,542
|
|||||||||
Income taxes (note 18)
|
7,764
|
5,036
|
4,286
|
|||||||||
Net earnings for the year
|
$
|
8,900
|
$
|
4,857
|
$
|
256
|
||||||
Basic net earnings per share
|
$
|
0.17
|
$
|
0.09
|
$
|
0.00
|
||||||
Diluted net earnings per share
|
$
|
0.16
|
$
|
0.08
|
$
|
0.00
|
||||||
Basic weighted average number of shares outstanding (000's)
|
53,863
|
56,804
|
60,329
|
|||||||||
Diluted weighted average number of shares outstanding (000's) (note 19)
|
54,669
|
57,457
|
61,015
|
(1)
|
The cost of sales is exclusive of depreciation and amortization, shown separately.
|
(2)
|
Selling and administrative is exclusive of unusual charge, which represents bad debt expenses.
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Net earnings for the year
|
$
|
8,900
|
$
|
4,857
|
$
|
256
|
||||||
Other comprehensive income (loss), net of income taxes
|
||||||||||||
Items that will not be reclassified subsequently to net earnings
|
||||||||||||
Foreign currency translation adjustment
|
707
|
(39,175
|
)
|
(7,086
|
)
|
|||||||
Items that may be reclassified subsequently to net earnings
|
||||||||||||
Unrealized gains/losses on forward exchange contracts
|
862
|
(5,583
|
)
|
(618
|
)
|
|||||||
Reclassification of realized gains/losses on forward exchange contracts in net earnings
|
2,797
|
2,107
|
959
|
|||||||||
Deferred income tax effect of gains/losses on forward exchange contracts
|
(935
|
)
|
905
|
(91
|
)
|
|||||||
Other comprehensive income (loss)
|
3,431
|
(41,746
|
)
|
(6,836
|
)
|
|||||||
Comprehensive income (loss) for the year
|
$
|
12,331
|
$
|
(36,889
|
)
|
$
|
(6,580
|
)
|
Year ended August 31, 2014
|
||||||||||||||||||||
Share
capital |
Contributed
surplus |
Retained
earnings |
Accumulated
other comprehensive loss |
Total
shareholders' equity |
||||||||||||||||
Balance as at September 1, 2013
|
$
|
109,837
|
$
|
17,186
|
$
|
112,296
|
$
|
(3,423
|
)
|
$
|
235,896
|
|||||||||
Exercise of stock options (note 12)
|
225
|
–
|
–
|
–
|
225
|
|||||||||||||||
Redemption of share capital (note 12)
|
(831
|
)
|
(106
|
)
|
–
|
–
|
(937
|
)
|
||||||||||||
Reclassification of stock-based compensation costs (note 12)
|
2,260
|
(2,260
|
)
|
–
|
–
|
–
|
||||||||||||||
Stock-based compensation costs
|
–
|
1,683
|
–
|
–
|
1,683
|
|||||||||||||||
Net earnings for the year
|
–
|
–
|
256
|
–
|
256
|
|||||||||||||||
Other comprehensive income (loss)
|
||||||||||||||||||||
Foreign currency translation adjustment
|
–
|
–
|
–
|
(7,086
|
)
|
(7,086
|
)
|
|||||||||||||
Changes in unrealized losses on forward exchange contracts, net of deferred income taxes of $91
|
–
|
–
|
–
|
250
|
250
|
|||||||||||||||
Total comprehensive loss for the year
|
(6,580
|
)
|
||||||||||||||||||
Balance as at August 31, 2014
|
$
|
111,491
|
$
|
16,503
|
$
|
112,552
|
$
|
(10,259
|
)
|
$
|
230,287
|
Year ended August 31, 2015
|
||||||||||||||||||||
Share
capital |
Contributed
surplus |
Retained
earnings |
Accumulated
other comprehensive loss |
Total
shareholders' equity |
||||||||||||||||
Balance as at September 1, 2014
|
$
|
111,491
|
$
|
16,503
|
$
|
112,552
|
$
|
(10,259
|
)
|
$
|
230,287
|
|||||||||
Redemption of share capital (note 12)
|
(26,827
|
)
|
1,333
|
–
|
–
|
(25,494
|
)
|
|||||||||||||
Reclassification of stock-based compensation costs (note 12)
|
1,381
|
(1,381
|
)
|
–
|
–
|
–
|
||||||||||||||
Stock-based compensation costs
|
–
|
1,323
|
–
|
–
|
1,323
|
|||||||||||||||
Net earnings for the year
|
–
|
–
|
4,857
|
–
|
4,857
|
|||||||||||||||
Other comprehensive loss
|
||||||||||||||||||||
Foreign currency translation adjustment
|
–
|
–
|
–
|
(39,175
|
)
|
(39,175
|
)
|
|||||||||||||
Changes in unrealized losses on forward exchange contracts, net of deferred income taxes of $905
|
–
|
–
|
–
|
(2,571
|
)
|
(2,571
|
)
|
|||||||||||||
Total comprehensive loss for the year
|
(36,889
|
)
|
||||||||||||||||||
Balance as at August 31, 2015
|
$
|
86,045
|
$
|
17,778
|
$
|
117,409
|
$
|
(52,005
|
)
|
$
|
169,227
|
Year ended August 31, 2016
|
||||||||||||||||||||
Share
capital |
Contributed
surplus |
Retained
earnings |
Accumulated
other comprehensive loss |
Total
shareholders' equity |
||||||||||||||||
Balance as at September 1, 2015
|
$
|
86,045
|
$
|
17,778
|
$
|
117,409
|
$
|
(52,005
|
)
|
$
|
169,227
|
|||||||||
Redemption of share capital (note 12)
|
(1,768
|
)
|
217
|
–
|
–
|
(1,551
|
)
|
|||||||||||||
Reclassification of stock-based compensation costs (note 12)
|
1,239
|
(1,239
|
)
|
–
|
–
|
–
|
||||||||||||||
Stock-based compensation costs
|
–
|
1,394
|
–
|
–
|
1,394
|
|||||||||||||||
Net earnings for the year
|
–
|
–
|
8,900
|
–
|
8,900
|
|||||||||||||||
Other comprehensive income (loss)
|
||||||||||||||||||||
Foreign currency translation adjustment
|
–
|
–
|
–
|
707
|
707
|
|||||||||||||||
Changes in unrealized gains/losses on forward exchange contracts, net of deferred income taxes of $935
|
–
|
–
|
–
|
2,724
|
2,724
|
|||||||||||||||
Total comprehensive income for the year
|
12,331
|
|||||||||||||||||||
Balance as at August 31, 2016
|
$
|
85,516
|
$
|
18,150
|
$
|
126,309
|
$
|
(48,574
|
)
|
$
|
181,401
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Cash flows from operating activities
|
||||||||||||
Net earnings for the year
|
$
|
8,900
|
$
|
4,857
|
$
|
256
|
||||||
Add (deduct) items not affecting cash
|
||||||||||||
Stock-based compensation costs
|
1,378
|
1,295
|
1,696
|
|||||||||
Depreciation and amortization
|
4,986
|
7,718
|
9,393
|
|||||||||
Unusual charge
|
–
|
603
|
720
|
|||||||||
Deferred revenue
|
4,238
|
396
|
(804
|
)
|
||||||||
Deferred income taxes
|
1,578
|
403
|
698
|
|||||||||
Changes in foreign exchange gain/loss
|
(332
|
)
|
(3,842
|
)
|
(491
|
)
|
||||||
20,748
|
11,430
|
11,468
|
||||||||||
Changes in non-cash operating items
|
||||||||||||
Accounts receivable
|
2,682
|
(10,828
|
)
|
3,578
|
||||||||
Income taxes and tax credits
|
939
|
(2,062
|
)
|
1,447
|
||||||||
Inventories
|
(4,713
|
)
|
820
|
(734
|
)
|
|||||||
Prepaid expenses
|
(280
|
)
|
(982
|
)
|
210
|
|||||||
Other assets
|
170
|
61
|
92
|
|||||||||
Accounts payable and accrued liabilities and provisions
|
4,882
|
8,132
|
3,832
|
|||||||||
Other liabilities
|
(65
|
)
|
(87
|
)
|
(107
|
)
|
||||||
24,363
|
6,484
|
19,786
|
||||||||||
Cash flows from investing activities
|
||||||||||||
Additions to short-term investments
|
(3,546
|
)
|
(20,067
|
)
|
(34,222
|
)
|
||||||
Proceeds from disposal and maturity of short-term investments
|
873
|
23,685
|
33,208
|
|||||||||
Purchases of capital assets (notes 7 and 8)
|
(4,356
|
)
|
(5,933
|
)
|
(7,931
|
)
|
||||||
(7,029
|
)
|
(2,315
|
)
|
(8,945
|
)
|
|||||||
Cash flows from financing activities
|
||||||||||||
Repayment of long-term debt
|
‒
|
‒
|
(307
|
)
|
||||||||
Exercise of stock options (note 12)
|
‒
|
‒
|
225
|
|||||||||
Redemption of share capital (note 12)
|
(1,551
|
)
|
(25,494
|
)
|
(937
|
)
|
||||||
(1,551
|
)
|
(25,494
|
)
|
(1,019
|
)
|
|||||||
Effect of foreign exchange rate changes on cash
|
1,561
|
(6,932
|
)
|
(1,087
|
)
|
|||||||
Change in cash
|
17,344
|
(28,257
|
)
|
8,735
|
||||||||
Cash – Beginning of year
|
25,864
|
54,121
|
45,386
|
|||||||||
Cash – End of year
|
$
|
43,208
|
$
|
25,864
|
$
|
54,121
|
||||||
Supplementary information
|
||||||||||||
Income taxes paid
|
$
|
2,015
|
$
|
1,491
|
$
|
1,272
|
1
|
Nature of Activities and Incorporation
|
As at August 31, 2016
|
||||||||||||
As reported
|
Adjustment
|
Revised
|
||||||||||
Revision to Consolidated Balance Sheet
|
||||||||||||
Accounts receivable - Trade
|
$
|
45,076
|
$
|
(2,083
|
)
|
$
|
42,993
|
|||||
Deferred income tax assets
|
$
|
7,681
|
$
|
559
|
$
|
8,240
|
||||||
Retained earnings
|
$
|
127,833
|
$
|
(1,524
|
)
|
$
|
126,309
|
|||||
Total assets
|
$
|
239,317
|
$
|
(1,524
|
)
|
$
|
237,793
|
|||||
Shareholders' equity
|
$
|
182,925
|
$
|
(1,524
|
)
|
$
|
181,401
|
|||||
As at and for the year ended August 31, 2015
|
||||||||||||
As reported
|
Adjustment
|
Revised
|
||||||||||
Revision to Consolidated Balance Sheet
|
||||||||||||
Accounts receivable - Trade
|
$
|
48,068
|
$
|
(2,083
|
)
|
$
|
45,985
|
|||||
Deferred income tax assets
|
$
|
8,900
|
$
|
559
|
$
|
9,459
|
||||||
Retained earnings
|
$
|
118,933
|
$
|
(1,524
|
)
|
$
|
117,409
|
|||||
Total assets
|
$
|
219,002
|
$
|
(1,524
|
)
|
$
|
217,478
|
|||||
Shareholders' equity
|
$
|
170,751
|
$
|
(1,524
|
)
|
$
|
169,227
|
|||||
Revision to Consolidated Statement of Earnings and Consolidated Statement of Comprehensive Income (Loss)
|
||||||||||||
Unusual charge (1)
|
$
|
–
|
$
|
603
|
$
|
603
|
||||||
Earnings before income taxes
|
$
|
10,496
|
$
|
(603
|
)
|
$
|
9,893
|
|||||
Deferred income tax expense
|
$
|
565
|
$
|
(162
|
)
|
$
|
403
|
|||||
Net earnings for the year
|
$
|
5,298
|
$
|
(441
|
)
|
$
|
4,857
|
|||||
Basic net earnings per share for the year
|
$
|
0.09
|
$
|
–
|
$
|
0.09
|
||||||
Diluted net earnings per share for the year
|
$
|
0.09
|
$
|
(0.01
|
)
|
$
|
0.08
|
|||||
Comprehensive loss for the year
|
$
|
(36,448
|
)
|
$
|
(441
|
)
|
$
|
(36,889
|
)
|
(1)
|
Adjustment to recognize bad debt expense in connection with a past due trade receivable balance, for which, upon correction of the aging, management would have provided an allowance in accordance with the company's credit provision policies.
|
As at and for the year ended August 31, 2014
|
||||||||||||
As reported
|
Adjustment
|
Revised
|
||||||||||
Revision to Consolidated Balance Sheet
|
||||||||||||
Retained earnings
|
$
|
113,635
|
$
|
(1,083
|
)
|
$
|
112,552
|
|||||
Revision to Consolidated Statement of Earnings and Consolidated Statement of Comprehensive Income (Loss)
|
||||||||||||
Unusual charge (2)
|
$
|
–
|
$
|
720
|
$
|
720
|
||||||
Earnings before income taxes
|
$
|
5,262
|
$
|
(720
|
)
|
$
|
4,542
|
|||||
Deferred income tax expense
|
$
|
891
|
$
|
(193
|
)
|
$
|
698
|
|||||
Net earnings for the year
|
$
|
783
|
$
|
(527
|
)
|
$
|
256
|
|||||
Basic and diluted net earnings per share for the year
|
$
|
0.01
|
$
|
(0.01
|
)
|
$
|
0.00
|
|||||
Comprehensive loss for the year
|
$
|
(6,053
|
)
|
$
|
(527
|
)
|
$
|
(6,580
|
)
|
(2)
|
Adjustment to recognize bad debt expense in connection with a past due trade receivable balance, for which, upon correction of the aging, management would have provided an allowance in accordance with the company's credit provision policies.
|
As at August 31, 2013
|
||||||||||||
As reported
|
Adjustment
|
Revised
|
||||||||||
Revision to Consolidated Balance Sheet
|
||||||||||||
Retained earnings (3)
|
$
|
112,852
|
$
|
(556
|
)
|
$
|
112,296
|
(3)
|
Adjustment to opening retained earnings as at September 1, 2013 in connection with a past due trade receivable balance, for which, upon correction of the aging, management would have provided an allowance in accordance with the company's credit provision policies.
|
2
|
Basis of Presentation
|
Cash
|
Loans and receivables
|
Short-term investments
|
Available for sale
|
Accounts receivable
|
Loans and receivables
|
Other assets
|
Loans and receivables
|
Accounts payable and accrued liabilities
|
Other financial liabilities
|
Level 1: |
Quoted prices (unadjusted) in active market for identical assets or liabilities;
|
Level 2: |
Inputs other than quoted prices included within Level 1 that are observable for the asset and liability, either directly or indirectly;
|
Level 3: |
Unobservable inputs for the asset or liability.
|
Term
|
|
Land improvements
|
15 years
|
Buildings
|
20 to 60 years
|
Equipment
|
3 to 15 years
|
Leasehold improvements
|
The lesser of useful life and remaining lease term
|
(a)
|
Determination of functional currency
|
(b)
|
Determination of cash generating units and allocation of goodwill
|
(a)
|
Inventories
|
(b)
|
Income taxes
|
(c)
|
Tax credits recoverable
|
(d)
|
Impairment of non-financial assets
|
3
|
Restructuring Charges
|
4
|
Capital Disclosures
|
·
|
To maintain a flexible capital structure that optimizes the cost of capital at acceptable risk;
|
·
|
To sustain future development of the company, including research and development activities, market development and potential acquisitions of complementary businesses or products; and
|
·
|
To provide the company's shareholders with an appropriate return on their investment.
|
5
|
Financial Instruments
|
As at August 31, 2016
|
||||||||||||||||||||
Loans and
receivable |
Available
for sale |
Other
financial liabilities |
Derivatives
used for hedging |
Total
|
||||||||||||||||
Financial assets
|
||||||||||||||||||||
Cash
|
$
|
43,208
|
$
|
–
|
$
|
–
|
$
|
–
|
$
|
43,208
|
||||||||||
Short-term investments
|
$
|
–
|
$
|
4,087
|
$
|
–
|
$
|
–
|
$
|
4,087
|
||||||||||
Accounts receivable
|
$
|
45,467
|
$
|
–
|
$
|
–
|
$
|
–
|
$
|
45,467
|
||||||||||
Other assets
|
$
|
35
|
$
|
–
|
$
|
–
|
$
|
–
|
$
|
35
|
||||||||||
Forward exchange contracts
|
$
|
–
|
$
|
–
|
$
|
–
|
$
|
980
|
$
|
980
|
||||||||||
Financial liabilities
|
||||||||||||||||||||
Accounts payable and accrued liabilities
|
$
|
–
|
$
|
–
|
$
|
36,099
|
$
|
–
|
$
|
36,099
|
||||||||||
Forward exchange contracts
|
$
|
–
|
$
|
–
|
$
|
–
|
$
|
1,120
|
$
|
1,120
|
As at August 31, 2015
|
||||||||||||||||||||
Loans and
receivable |
Available
for sale |
Other
financial liabilities |
Derivatives
used for hedging |
Total
|
||||||||||||||||
Financial assets
|
||||||||||||||||||||
Cash
|
$
|
25,864
|
$
|
–
|
$
|
–
|
$
|
–
|
$
|
25,864
|
||||||||||
Short-term investments
|
$
|
–
|
$
|
1,487
|
$
|
–
|
$
|
–
|
$
|
1,487
|
||||||||||
Accounts receivable
|
$
|
48,369
|
$
|
–
|
$
|
–
|
$
|
–
|
$
|
48,369
|
||||||||||
Other assets
|
$
|
103
|
$
|
–
|
$
|
–
|
$
|
–
|
$
|
103
|
||||||||||
Financial liabilities
|
||||||||||||||||||||
Accounts payable and accrued liabilities
|
$
|
–
|
$
|
–
|
$
|
29,029
|
$
|
–
|
$
|
29,029
|
||||||||||
Forward exchange contracts
|
$
|
–
|
$
|
–
|
$
|
–
|
$
|
4,154
|
$
|
4,154
|
As at August 31, 2016
|
As at August 31, 2015
|
|||||||||||||||
Level 1
|
Level 2
|
Level 1
|
Level 2
|
|||||||||||||
Financial assets
|
||||||||||||||||
Short-term investments
|
$
|
4,087
|
$
|
–
|
$
|
1,487
|
$
|
–
|
||||||||
Forward exchange contracts
|
$
|
–
|
$
|
980
|
$
|
–
|
$
|
–
|
||||||||
Financial liabilities
|
||||||||||||||||
Forward exchange contracts
|
$
|
–
|
$
|
1,120
|
$
|
–
|
$
|
4,154
|
Expiry dates
|
Contractual
amounts |
Weighted average
contractual forward rates |
||||||
As at August 31, 2015
|
||||||||
September 2015 to August 2016
|
$
|
20,200
|
1.1180
|
|||||
September 2016 to August 2017
|
8,000
|
1.1530
|
||||||
September 2017 to December 2017
|
1,600
|
1.2135
|
||||||
Total
|
$
|
29,800
|
1.1326
|
|||||
As at August 31, 2016
|
||||||||
September 2016 to August 2017
|
$
|
22,200
|
1.2784
|
|||||
September 2017 to August 2018
|
9,900
|
1.3367
|
||||||
September 2018 to December 2018
|
1,900
|
1.3639
|
||||||
Total
|
$
|
34,000
|
1.3002
|
Expiry dates
|
Contractual
amounts |
Weighted average
contractual forward rates |
||||||
As at August 31, 2015
|
||||||||
September 2015 to July 2016
|
$
|
3,900
|
66.41
|
|||||
As at August 31, 2016
|
||||||||
September 2016 to August 2017
|
$
|
3,800
|
70.92
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Losses on forward exchange contracts
|
$
|
2,651
|
$
|
2,562
|
$
|
909
|
As at August 31,
|
||||||||||||||||
2016
|
2015
|
|||||||||||||||
Carrying/nominal
amount (in thousands
of US dollars)
|
Carrying/nominal
amount (in thousands
of euros)
|
Carrying/nominal
amount (in thousands
of US dollars)
|
Carrying/nominal
amount (in thousands
of euros)
|
|||||||||||||
Financial assets
|
||||||||||||||||
Cash
|
$
|
13,090
|
€
|
2,927
|
$
|
9,226
|
€
|
3,448
|
||||||||
Accounts receivable
|
30,141
|
5,963
|
37,019
|
4,488
|
||||||||||||
43,231
|
8,890
|
46,245
|
7,936
|
|||||||||||||
Financial liabilities
|
||||||||||||||||
Accounts payable and accrued liabilities
|
14,251
|
1,081
|
12,873
|
1,047
|
||||||||||||
Forward exchange contracts (nominal value)
|
4,000
|
–
|
3,800
|
–
|
||||||||||||
18,251
|
1,081
|
16,673
|
1,047
|
|||||||||||||
Net exposure
|
$
|
24,980
|
€
|
7,809
|
$
|
29,572
|
€
|
6,889
|
·
|
An increase (decrease) of 10% in the period-end value of the Canadian dollar compared to the US dollar would decrease (increase) net earnings by $2,677,000, or $0.05 per diluted share, and $2,342,000, or $0.04 per diluted share, as at August 31, 2015 and 2016 respectively.
|
·
|
An increase (decrease) of 10% in the period-end value of the Canadian dollar compared to the euro would decrease (increase) net earnings by $834,000, or $0.01 per diluted share, and $830,000 or $0.02 per diluted share, as at August 31, 2015 and 2016 respectively.
|
·
|
An increase (decrease) of 10% in the period-end value of the Canadian dollar compared to the US dollar would increase (decrease) other comprehensive income by $2,066,000 and $2,176,000 as at August 31, 2015 and 2016 respectively.
|
As at August 31
|
||||||||
2016
|
2015
|
|||||||
Term deposit denominated in Canadian dollars, bearing interest at an annual rate of 1.5%, maturing in May 2017
|
$
|
2,668
|
$
|
–
|
||||
Term deposits denominated in Indian rupees, bearing interest at annual rates of 6.0% to 7.3% in 2016 and 4.5% to 8.5% in 2015, maturing on different dates between November 2016 and October 2018 in 2016 and November 2015 and October 2018 in 2015
|
1,419
|
1,487
|
||||||
$
|
4,087
|
$
|
1,487
|
As at August 31,
|
||||||||
2016
|
2015
|
|||||||
Current
|
$
|
38,411
|
$
|
36,723
|
||||
Past due, 0 to 30 days
|
1,286
|
5,164
|
||||||
Past due, 31 to 60 days
|
868
|
1,027
|
||||||
Past due, more than 60 days, net of allowance for doubtful accounts of $2,935 and $3,752 as at August 31, 2015 and 2016, respectively
|
2,428
|
3,071
|
||||||
$
|
42,993
|
$
|
45,985
|
Years ended August 31,
|
||||||||
2016
|
2015
|
|||||||
Balance – Beginning of year
|
$
|
2,935
|
$
|
1,876
|
||||
Addition charged to earnings
|
817
|
1,107
|
||||||
Write-off of uncollectible accounts
|
‒
|
(48
|
)
|
|||||
Balance – End of year
|
$
|
3,752
|
$
|
2,935
|
As at August 31, 2016
|
||||||||||||
0-12
months |
13-24
months |
25-36
months |
||||||||||
Accounts payable and accrued liabilities
|
$
|
36,099
|
$
|
‒
|
$
|
‒
|
||||||
Forward exchange contracts
|
||||||||||||
Outflow
|
26,000
|
9,900
|
1,900
|
|||||||||
Inflow
|
(25,653
|
)
|
(10,089
|
)
|
(1,976
|
)
|
||||||
Total
|
$
|
36,446
|
$
|
(189
|
)
|
$
|
(76
|
)
|
As at August 31, 2015
|
||||||||||||
0-12
months |
13-24
months |
25-36
months |
||||||||||
Accounts payable and accrued liabilities
|
$
|
29,029
|
$
|
‒
|
$
|
‒
|
||||||
Forward exchange contracts
|
||||||||||||
Outflow
|
24,100
|
8,000
|
1,600
|
|||||||||
Inflow
|
(21,082
|
)
|
(7,011
|
)
|
(1,476
|
)
|
||||||
Total
|
$
|
32,047
|
$
|
989
|
$
|
124
|
6
|
Inventories
|
As at August 31,
|
||||||||
2016
|
2015
|
|||||||
Raw materials
|
$
|
18,692
|
$
|
15,972
|
||||
Work in progress
|
1,067
|
998
|
||||||
Finished goods
|
13,245
|
10,981
|
||||||
$
|
33,004
|
$
|
27,951
|
7
|
Property, Plant and Equipment
|
Land and land
improvements |
Buildings
|
Equipment
|
Leasehold
improvements |
Total
|
||||||||||||||||
Cost as at September 1, 2014
|
$
|
5,222
|
$
|
35,597
|
$
|
38,970
|
$
|
2,442
|
$
|
82,231
|
||||||||||
Additions
|
‒
|
153
|
3,638
|
1,443
|
5,234
|
|||||||||||||||
Disposals
|
‒
|
(12
|
)
|
(4,999
|
)
|
(753
|
)
|
(5,764
|
)
|
|||||||||||
Foreign currency translation adjustment
|
(913
|
)
|
(6,266
|
)
|
(6,400
|
)
|
(338
|
)
|
(13,917
|
)
|
||||||||||
Cost as at August 31, 2015
|
4,309
|
29,472
|
31,209
|
2,794
|
67,784
|
|||||||||||||||
Additions
|
‒
|
201
|
3,626
|
226
|
4,053
|
|||||||||||||||
Disposals
|
‒
|
(11
|
)
|
(4,280
|
)
|
(121
|
)
|
(4,412
|
)
|
|||||||||||
Foreign currency translation adjustment
|
13
|
93
|
162
|
19
|
287
|
|||||||||||||||
Cost as at August 31, 2016
|
$
|
4,322
|
$
|
29,755
|
$
|
30,717
|
$
|
2,918
|
$
|
67,712
|
||||||||||
Accumulated depreciation as at September 1, 2014
|
$
|
1,327
|
$
|
6,984
|
$
|
29,888
|
$
|
1,252
|
$
|
39,451
|
||||||||||
Depreciation for the year
|
51
|
485
|
3,919
|
380
|
4,835
|
|||||||||||||||
Disposals
|
‒
|
(12
|
)
|
(4,999
|
)
|
(753
|
)
|
(5,764
|
)
|
|||||||||||
Foreign currency translation adjustment
|
(236
|
)
|
(1,514
|
)
|
(4,595
|
)
|
(88
|
)
|
(6,433
|
)
|
||||||||||
Accumulated depreciation as at August 31, 2015
|
1,142
|
5,943
|
24,213
|
791
|
32,089
|
|||||||||||||||
Depreciation for the year
|
45
|
639
|
2,811
|
319
|
3,814
|
|||||||||||||||
Disposals
|
‒
|
(11
|
)
|
(4,258
|
)
|
(121
|
)
|
(4,390
|
)
|
|||||||||||
Foreign currency translation adjustment
|
5
|
31
|
136
|
49
|
221
|
|||||||||||||||
Accumulated depreciation as at August 31, 2016
|
$
|
1,192
|
$
|
6,602
|
$
|
22,902
|
$
|
1,038
|
$
|
31,734
|
||||||||||
Net carrying value as at:
|
||||||||||||||||||||
August 31, 2015
|
$
|
3,167
|
$
|
23,529
|
$
|
6,996
|
$
|
2,003
|
$
|
35,695
|
||||||||||
August 31, 2016
|
$
|
3,130
|
$
|
23,153
|
$
|
7,815
|
$
|
1,880
|
$
|
35,978
|
8
|
Intangible Assets and Goodwill
|
Core
technology |
Customer
relationships |
Brand name
|
Software
|
Total
|
||||||||||||||||
Cost as at September 1, 2014
|
$
|
12,686
|
$
|
5,979
|
$
|
596
|
$
|
12,925
|
$
|
32,186
|
||||||||||
Additions
|
153
|
‒
|
‒
|
567
|
720
|
|||||||||||||||
Disposals
|
(93
|
)
|
‒
|
‒
|
(652
|
)
|
(745
|
)
|
||||||||||||
Foreign currency translation adjustment
|
(2,225
|
)
|
(1,044
|
)
|
(104
|
)
|
(2,112
|
)
|
(5,485
|
)
|
||||||||||
Cost as at August 31, 2015
|
10,521
|
4,935
|
492
|
10,728
|
26,676
|
|||||||||||||||
Additions
|
147
|
‒
|
‒
|
313
|
460
|
|||||||||||||||
Disposals
|
(6,414
|
)
|
(4,935
|
)
|
(492
|
)
|
(310
|
)
|
(12,151
|
)
|
||||||||||
Foreign currency translation adjustment
|
48
|
‒
|
‒
|
112
|
160
|
|||||||||||||||
Cost as at August 31, 2016
|
$
|
4,302
|
$
|
‒
|
$
|
‒
|
$
|
10,843
|
$
|
15,145
|
||||||||||
Accumulated amortization as at September 1, 2014
|
$
|
8,062
|
$
|
5,346
|
$
|
534
|
$
|
10,951
|
$
|
24,893
|
||||||||||
Amortization for the year
|
808
|
569
|
57
|
1,449
|
2,883
|
|||||||||||||||
Disposals
|
(93
|
)
|
‒
|
‒
|
(652
|
)
|
(745
|
)
|
||||||||||||
Foreign currency translation adjustment
|
(865
|
)
|
(980
|
)
|
(99
|
)
|
(2,507
|
)
|
(4,451
|
)
|
||||||||||
Accumulated amortization as at August 31, 2015
|
7,912
|
4,935
|
492
|
9,241
|
22,580
|
|||||||||||||||
Amortization for the year
|
700
|
‒
|
‒
|
472
|
1,172
|
|||||||||||||||
Disposals
|
(6,414
|
)
|
(4,935
|
)
|
(492
|
)
|
(297
|
)
|
(12,138
|
)
|
||||||||||
Foreign currency translation adjustment
|
109
|
‒
|
‒
|
31
|
140
|
|||||||||||||||
Accumulated amortization as at August 31, 2016
|
$
|
2,307
|
$
|
‒
|
$
|
‒
|
$
|
9,447
|
$
|
11,754
|
||||||||||
Net carrying value as at:
|
||||||||||||||||||||
August 31, 2015
|
$
|
2,609
|
$
|
‒
|
$
|
‒
|
$
|
1,487
|
$
|
4,096
|
||||||||||
August 31, 2016
|
$
|
1,995
|
$
|
‒
|
$
|
‒
|
$
|
1,396
|
$
|
3,391
|
||||||||||
Remaining amortization period as at August 31, 2016
|
3 years
|
‒
|
‒
|
4 years
|
Years ended August 31,
|
||||||||
2016
|
2015
|
|||||||
Balance – Beginning of year
|
$
|
21,860
|
$
|
26,488
|
||||
Foreign currency translation adjustment
|
68
|
(4,628
|
)
|
|||||
Balance – End of year
|
$
|
21,928
|
$
|
21,860
|
As at August 31,
|
||||||||
2016
|
2015
|
|||||||
EXFO CGU
|
$
|
8,663
|
$
|
8,636
|
||||
Brix CGU
|
13,265
|
13,224
|
||||||
Total
|
$
|
21,928
|
$
|
21,860
|
9
|
Credit Facilities
|
10
|
Accounts Payable and Accrued Liabilities
|
As at August 31,
|
||||||||
2016
|
2015
|
|||||||
Trade
|
$
|
16,940
|
$
|
14,402
|
||||
Salaries and social benefits
|
16,188
|
11,088
|
||||||
Forward exchange contracts (note 5)
|
1,075
|
3,460
|
||||||
Restructuring charges (note 3)
|
‒
|
1,637
|
||||||
Other
|
2,971
|
3,539
|
||||||
$
|
37,174
|
$
|
34,126
|
11
|
Commitments
|
As at August 31,
|
||||||||
2016
|
2015
|
|||||||
No later than 1 year
|
$
|
3,337
|
$
|
2,112
|
||||
Later than 1 year and no later than 5 years
|
3,876
|
3,620
|
||||||
Later than 5 years
|
1,037
|
1,766
|
||||||
$
|
8,250
|
$
|
7,498
|
12
|
Share Capital
|
Authorized – unlimited as to number, without par value
|
|
Subordinate voting and participating, bearing a non-cumulative dividend to be determined by the Board of Directors, ranking pari passu with multiple voting shares
|
|
Multiple voting and participating, entitling to 10 votes each, bearing a non-cumulative dividend to be determined by the Board of Directors, convertible at the holder's option into subordinate voting shares on a one-for-one basis, ranking pari passu with subordinate voting shares
|
Multiple Voting Shares
|
Subordinate Voting Shares
|
|||||||||||||||||||
Number
|
Amount
|
Number
|
Amount
|
Total
amount
|
||||||||||||||||
Balance as at September 1, 2013
|
31,643,000
|
$
|
1
|
28,401,790
|
$
|
109,836
|
$
|
109,837
|
||||||||||||
Exercise of stock options (note 14)
|
‒
|
–
|
52,800
|
225
|
225
|
|||||||||||||||
Redemption of restricted share units (note 14)
|
‒
|
–
|
425,620
|
–
|
–
|
|||||||||||||||
Redemption of deferred share units (note 14)
|
‒
|
–
|
38,010
|
–
|
–
|
|||||||||||||||
Redemption of share capital
|
‒
|
–
|
(214,470
|
)
|
(831
|
)
|
(831
|
)
|
||||||||||||
Reclassification of stock-based compensation costs to share capital upon exercise of stock awards
|
‒
|
–
|
–
|
2,260
|
2,260
|
|||||||||||||||
Balance as at August 31, 2014
|
31,643,000
|
1
|
28,703,750
|
111,490
|
111,491
|
|||||||||||||||
Redemption of restricted share units (note 14)
|
‒
|
–
|
229,559
|
–
|
–
|
|||||||||||||||
Redemption of deferred share units (note 14)
|
‒
|
–
|
48,697
|
–
|
–
|
|||||||||||||||
Redemption of share capital
|
‒
|
–
|
(6,889,972
|
)
|
(26,827
|
)
|
(26,827
|
)
|
||||||||||||
Reclassification of stock-based compensation costs to share capital upon exercise of stock awards
|
–
|
–
|
–
|
1,381
|
1,381
|
|||||||||||||||
Balance as at August 31, 2015
|
31,643,000
|
1
|
22,092,034
|
86,044
|
86,045
|
|||||||||||||||
Redemption of restricted share units (note 14)
|
–
|
–
|
277,805
|
–
|
–
|
|||||||||||||||
Redemption of deferred share units (note 14)
|
–
|
–
|
653
|
–
|
–
|
|||||||||||||||
Redemption of share capital
|
–
|
–
|
(452,550
|
)
|
(1,768
|
)
|
(1,768
|
)
|
||||||||||||
Reclassification of stock-based compensation costs to share capital upon exercise of stock awards
|
–
|
–
|
–
|
1,239
|
1,239
|
|||||||||||||||
Balance as at August 31, 2016
|
31,643,000
|
$
|
1
|
21,917,942
|
$
|
85,515
|
$
|
85,516
|
a)
|
On January 8, 2014, the company announced that its Board of Directors had approved the renewal of its share repurchase program, by way of a normal course issuer bid on the open market of up to 10% of its issued and outstanding subordinate voting shares, representing 2,043,101 subordinate voting shares at the prevailing market price. The normal course issuer bid started on January 13, 2014, and ended on January 12, 2015. All shares repurchased under the bid were cancelled.
|
b)
|
On January 7, 2015, the company announced that its Board of Directors had authorized a substantial issuer bid (the "Offer") to purchase for cancellation up to 7,142,857 subordinate voting shares for an aggregate purchase price not to exceed CA$30,000,000. On February 20, 2015, pursuant to the Offer, the company purchased for cancellation 6,521,739 subordinate voting shares for an aggregate purchase price of CA$30,000,000 (US$24,027,000), plus related fees of $223,000. The company used cash to fund the purchase of shares.
|
c)
|
On March 25, 2015, the company announced that its Board of Directors had approved the renewal of its share repurchase program, by way of a normal course issuer bid on the open market of up to 10% of the issued and outstanding subordinate voting shares, representing 1,397,598 subordinate voting shares at the prevailing market price. The normal course issuer bid started on March 27, 2015, and ended on March 26, 2016. All shares repurchased under the bid were cancelled.
|
d)
|
On March 29, 2016, the company announced that its Board of Directors had approved the renewal of its share repurchase program, by way of a normal course issuer bid on the open market of up to 6.6% of the issued and outstanding subordinate voting shares, representing 900,000 subordinate voting shares at the prevailing market price. The normal course issuer bid started on April 1, 2016, and will end on March 31, 2017, or on an earlier date if the company repurchases the maximum number of shares permitted under the bid. The program does not require that the company repurchases any specific number of shares, and it may be modified, suspended or terminated at any time and without prior notice. All shares repurchased under the bid are cancelled.
|
13
|
Accumulated Other Comprehensive Loss
|
Foreign
currency translation adjustment |
Cash-flow
hedge |
Accumulated
other comprehensive loss |
||||||||||
Balance as at September 1, 2013
|
$
|
(3,582
|
)
|
$
|
159
|
$
|
(3,423
|
)
|
||||
Foreign currency translation adjustment
|
(7,086
|
)
|
–
|
(7,086
|
)
|
|||||||
Changes in unrealized losses on forward exchange contracts, net of deferred income taxes
|
–
|
250
|
250
|
|||||||||
Balance as at August 31, 2014
|
(10,668
|
)
|
409
|
(10,259
|
)
|
|||||||
Foreign currency translation adjustment
|
(39,175
|
)
|
–
|
(39,175
|
)
|
|||||||
Changes in unrealized losses on forward exchange contracts, net of deferred income taxes
|
–
|
(2,571
|
)
|
(2,571
|
)
|
|||||||
Balance as at August 31, 2015
|
(49,843
|
)
|
(2,162
|
)
|
(52,005
|
)
|
||||||
Foreign currency translation adjustment
|
707
|
‒
|
707
|
|||||||||
Changes in unrealized gains/losses on forward exchange contracts, net of deferred income taxes
|
‒
|
2,724
|
2,724
|
|||||||||
Balance as at August 31, 2016
|
$
|
(49,136
|
)
|
$
|
562
|
$
|
(48,574
|
)
|
14
|
Stock-Based Compensation Plans
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Stock-based compensation costs arising from
equity-settled awards |
$
|
1,394
|
$
|
1,323
|
$
|
1,683
|
||||||
Stock-based compensation costs arising from
cash-settled awards |
(16
|
)
|
(28
|
)
|
13
|
|||||||
$
|
1,378
|
$
|
1,295
|
$
|
1,696
|
Years ended August 31,
|
||||||||||||||||||||||||
2016
|
2015
|
2014
|
||||||||||||||||||||||
Number
|
Weighted
average exercise price |
Number
|
Weighted
average exercise price |
Number
|
Weighted
average exercise price |
|||||||||||||||||||
(CA$)
|
(CA$)
|
(CA$)
|
||||||||||||||||||||||
Outstanding – Beginning of year
|
17,099
|
$
|
6
|
87,454
|
$
|
6
|
201,254
|
$
|
6
|
|||||||||||||||
Exercised
|
–
|
–
|
–
|
–
|
(52,800
|
)
|
5
|
|||||||||||||||||
Forfeited
|
–
|
–
|
(2,000
|
)
|
6
|
(4,500
|
)
|
6
|
||||||||||||||||
Expired
|
(17,099
|
)
|
6
|
(68,355
|
)
|
6
|
(56,500
|
)
|
6
|
|||||||||||||||
Outstanding – End of year
|
–
|
$
|
–
|
17,099
|
$
|
6
|
87,454
|
$
|
6
|
|||||||||||||||
Exercisable – End of year
|
–
|
$
|
–
|
17,099
|
$
|
6
|
87,454
|
$
|
6
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Outstanding – Beginning of year
|
1,299,958
|
1,225,135
|
1,333,092
|
|||||||||
Granted
|
572,008
|
409,521
|
336,685
|
|||||||||
Redeemed
|
(277,805
|
)
|
(229,559
|
)
|
(425,620
|
)
|
||||||
Forfeited
|
(42,606
|
)
|
(105,139
|
)
|
(19,022
|
)
|
||||||
Outstanding – End of year
|
1,551,555
|
1,299,958
|
1,225,135
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Outstanding – Beginning of year
|
114,810
|
117,701
|
119,908
|
|||||||||
Granted
|
44,970
|
45,806
|
35,803
|
|||||||||
Redeemed
|
(653
|
)
|
(48,697
|
)
|
(38,010
|
)
|
||||||
Outstanding – End of year
|
159,127
|
114,810
|
117,701
|
Years ended August 31,
|
||||||||||||||||||||||||
2016
|
2015
|
2014
|
||||||||||||||||||||||
Number
|
Weighted
average exercise price |
Number
|
Weighted
average exercise price |
Number
|
Weighted
average exercise price |
|||||||||||||||||||
Outstanding – Beginning of year
|
42,324
|
$
|
1
|
39,874
|
$
|
2
|
37,224
|
$
|
3
|
|||||||||||||||
Granted
|
7,800
|
–
|
6,150
|
–
|
7,150
|
–
|
||||||||||||||||||
Exercised
|
(12,927
|
)
|
5
|
(500
|
)
|
6
|
–
|
–
|
||||||||||||||||
Expired
|
(1,500
|
)
|
7
|
(2,000
|
)
|
5
|
(4,500
|
)
|
5
|
|||||||||||||||
Forfeited
|
(2,197
|
)
|
–
|
(1,200
|
)
|
6
|
–
|
–
|
||||||||||||||||
Outstanding – End of year
|
33,500
|
$
|
1
|
42,324
|
$
|
1
|
39,874
|
$
|
2
|
|||||||||||||||
Exercisable – End of year
|
14,000
|
$
|
3
|
22,924
|
$
|
3
|
22,374
|
$
|
3
|
Stock appreciation
rights outstanding |
Stock appreciation
rights exercisable |
|||||||||||
Exercise price
|
Number
|
Weighted average
remaining contractual life |
Number
|
|||||||||
$ –
|
|
19,500
|
8 years
|
–
|
||||||||
$2.36
|
|
8,250
|
2 years
|
8,250
|
||||||||
$3.74
|
|
4,000
|
3 years
|
4,000
|
||||||||
$6.28
|
|
1,750
|
1 year
|
1,750
|
||||||||
33,500
|
6 years
|
14,000
|
15
|
Related-Party Disclosures
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Salaries and short-term employee benefits
|
$
|
3,701
|
$
|
3,025
|
$
|
3,627
|
||||||
Stock-based compensation costs
|
826
|
617
|
906
|
|||||||||
$
|
4,527
|
$
|
3,642
|
$
|
4,533
|
|||||||
16
|
Statements of Earnings
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Gross research and development expenses
|
$
|
47,875
|
$
|
50,148
|
$
|
52,423
|
||||||
Research and development tax credits and grants
|
(5,188
|
)
|
(6,145
|
)
|
(7,577
|
)
|
||||||
Net research and development expenses for the year
|
$
|
42,687
|
$
|
44,003
|
$
|
44,846
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Cost of sales
|
||||||||||||
Depreciation of property, plant and equipment
|
$
|
1,290
|
$
|
1,519
|
$
|
1,522
|
||||||
Amortization of intangible assets
|
702
|
1,540
|
2,087
|
|||||||||
1,992
|
3,059
|
3,609
|
||||||||||
Selling and administrative expenses
|
||||||||||||
Depreciation of property, plant and equipment
|
501
|
524
|
951
|
|||||||||
Amortization of intangible assets
|
75
|
790
|
1,534
|
|||||||||
576
|
1,314
|
2,485
|
||||||||||
Net research and development expenses
|
||||||||||||
Depreciation of property, plant and equipment
|
2,023
|
2,792
|
2,522
|
|||||||||
Amortization of intangible assets
|
395
|
553
|
777
|
|||||||||
2,418
|
3,345
|
3,299
|
||||||||||
$
|
4,986
|
$
|
7,718
|
$
|
9,393
|
|||||||
Depreciation of property, plant and equipment
|
$
|
3,814
|
$
|
4,835
|
$
|
4,995
|
||||||
Amortization of intangible assets
|
1,172
|
2,883
|
4,398
|
|||||||||
Total depreciation and amortization expenses for the year
|
$
|
4,986
|
$
|
7,718
|
$
|
9,393
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Salaries and benefits
|
$
|
112,569
|
$
|
114,868
|
$
|
121,515
|
||||||
Restructuring charges
|
‒
|
1,637
|
‒
|
|||||||||
Stock-based compensation costs
|
1,378
|
1,295
|
1,696
|
|||||||||
Total employee compensation for the year
|
$
|
113,947
|
$
|
117,800
|
$
|
123,211
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Cost of sales
|
$
|
‒
|
$
|
290
|
$
|
‒
|
||||||
Selling and administrative expenses
|
‒
|
586
|
‒
|
|||||||||
Net research and development costs
|
‒
|
761
|
‒
|
|||||||||
Total restructuring charges for the year
|
$
|
‒
|
$
|
1,637
|
$
|
‒
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Cost of sales
|
$
|
107
|
$
|
159
|
$
|
191
|
||||||
Selling and administrative expenses
|
972
|
791
|
1,140
|
|||||||||
Net research and development expenses
|
299
|
345
|
365
|
|||||||||
Total stock-based compensation costs for the year
|
$
|
1,378
|
$
|
1,295
|
$
|
1,696
|
17
|
Other Disclosures
|
·
|
Canadian defined contribution pension plan
|
·
|
US defined contribution pension plan (401K plan)
|
18
|
Income Taxes
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Income tax provision at combined Canadian federal and provincial statutory tax rate (27%)
|
$
|
4,499
|
$
|
2,671
|
$
|
1,226
|
||||||
Increase (decrease) due to:
|
||||||||||||
Foreign income/loss taxed at different rates
|
(1,025
|
)
|
482
|
(20
|
)
|
|||||||
Non-taxable (income)/loss
|
5
|
2,540
|
(540
|
)
|
||||||||
Non-deductible expenses
|
411
|
664
|
1,011
|
|||||||||
Foreign exchange effect of translation of foreign subsidiaries in the functional currency
|
566
|
(3,641
|
)
|
(547
|
)
|
|||||||
Unrecognized deferred income tax assets on temporary deductible differences and unused tax losses
|
3,702
|
2,556
|
3,013
|
|||||||||
Other
|
(394
|
)
|
(236
|
)
|
143
|
|||||||
Income tax provision for the year
|
$
|
7,764
|
$
|
5,036
|
$
|
4,286
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
The income tax provision consists of the following:
|
||||||||||||
Current
|
||||||||||||
Current income taxes
|
$
|
6,186
|
$
|
4,633
|
$
|
3,588
|
||||||
Deferred
|
||||||||||||
Deferred income taxes relating to the origination and reversal of temporary differences
|
(2,124
|
)
|
(2,153
|
)
|
(2,315
|
)
|
||||||
Unrecognized deferred income tax assets on temporary deductible differences and unused tax losses
|
3,702
|
2,556
|
3,013
|
|||||||||
1,578
|
403
|
698
|
||||||||||
Income tax provision for the year
|
$
|
7,764
|
$
|
5,036
|
$
|
4,286
|
As at August 31,
|
||||||||
2016
|
2015
|
|||||||
Deferred income tax assets
|
||||||||
Deferred income tax assets recoverable within 12 months
|
$
|
4,224
|
$
|
3,512
|
||||
Deferred income tax assets recoverable after 12 months
|
4,016
|
5,947
|
||||||
8,240
|
9,459
|
|||||||
Deferred income tax liabilities
|
||||||||
Deferred income tax liabilities payable within 12 months
|
645
|
398
|
||||||
Deferred income tax liabilities payable after 12 months
|
2,212
|
1,126
|
||||||
2,857
|
1,524
|
|||||||
Deferred income tax assets net
|
$
|
5,383
|
$
|
7,935
|
Balance as at
September 1, 2014 |
Credited
(charged) to the statement of earnings |
Credited
(charged) to shareholders' equity |
Foreign
currency translation adjustment |
Balance as at
August 31, 2015 |
||||||||||||||||
Deferred income tax assets
|
||||||||||||||||||||
Long-lived assets
|
$
|
2,837
|
$
|
468
|
$
|
‒
|
$
|
(456
|
)
|
$
|
2,849
|
|||||||||
Provisions and accruals
|
4,335
|
422
|
905
|
(638
|
)
|
5,024
|
||||||||||||||
Deferred revenue
|
1,638
|
(156
|
)
|
‒
|
(174
|
)
|
1,308
|
|||||||||||||
Research and development expenses
|
2,732
|
(17
|
)
|
‒
|
(475
|
)
|
2,240
|
|||||||||||||
Losses carried forward
|
7,406
|
(819
|
)
|
‒
|
(36
|
)
|
6,551
|
|||||||||||||
Deferred income tax liabilities
|
||||||||||||||||||||
Long-lived assets
|
(41
|
)
|
41
|
‒
|
‒
|
‒
|
||||||||||||||
Research and development tax credits
|
(11,781
|
)
|
(342
|
)
|
‒
|
2,086
|
(10,037
|
)
|
||||||||||||
Total
|
$
|
7,126
|
$
|
(403
|
)
|
$
|
905
|
$
|
307
|
$
|
7,935
|
|||||||||
Classified as follows:
|
||||||||||||||||||||
Deferred income tax assets
|
$
|
10,213
|
$
|
9,459
|
||||||||||||||||
Deferred income tax liabilities
|
(3,087
|
)
|
(1,524
|
)
|
||||||||||||||||
$
|
7,126
|
$
|
7,935
|
Balance as at
September 1, 2015 |
Credited
(charged) to the statement of earnings |
Credited
(charged) to shareholders' equity |
Foreign
currency translation adjustment |
Balance as at
August 31, 2016 |
||||||||||||||||
Deferred income tax assets
|
||||||||||||||||||||
Long-lived assets
|
$
|
2,849
|
$
|
(595
|
)
|
$
|
‒
|
$
|
1
|
$
|
2,255
|
|||||||||
Provisions and accruals
|
5,024
|
177
|
(935
|
)
|
(20
|
)
|
4,246
|
|||||||||||||
Deferred revenue
|
1,308
|
1,015
|
‒
|
7
|
2,330
|
|||||||||||||||
Research and development expenses
|
2,240
|
112
|
‒
|
9
|
2,361
|
|||||||||||||||
Losses carried forward
|
6,551
|
(1,951
|
)
|
‒
|
(2
|
)
|
4,598
|
|||||||||||||
Deferred income tax liabilities
|
||||||||||||||||||||
Research and development tax credits
|
(10,037
|
)
|
(336
|
)
|
‒
|
(34
|
)
|
(10,407
|
)
|
|||||||||||
Total
|
$
|
7,935
|
$
|
(1,578
|
)
|
$
|
(935
|
)
|
$
|
(39
|
)
|
$
|
5,383
|
|||||||
Classified as follows:
|
||||||||||||||||||||
Deferred income tax assets
|
$
|
9,459
|
$
|
8,240
|
||||||||||||||||
Deferred income tax liabilities
|
(1,524
|
)
|
(2,857
|
)
|
||||||||||||||||
$
|
7,935
|
$
|
5,383
|
As at August 31,
|
||||||||
2016
|
2015
|
|||||||
Temporary deductible differences
|
$
|
1,676
|
$
|
1,433
|
||||
Losses carried forward
|
38,287
|
34,693
|
||||||
Research and development expenses
|
‒
|
221
|
||||||
$
|
39,963
|
$
|
36,347
|
Year of expiry
|
Finland
|
United States
|
||||||
2017
|
$
|
3
|
$
|
‒
|
||||
2018
|
418
|
741
|
||||||
2019
|
‒
|
3,470
|
||||||
2020
|
7,387
|
7,991
|
||||||
2021
|
6,400
|
2,211
|
||||||
2022
|
11,097
|
7,435
|
||||||
2023
|
7,189
|
1,972
|
||||||
2024
|
5,550
|
1,351
|
||||||
2025
|
6,918
|
1,351
|
||||||
2026
|
237
|
1,351
|
||||||
2027
|
‒
|
1,351
|
||||||
2028
|
‒
|
2,447
|
||||||
2030
|
‒
|
2,713
|
||||||
2031
|
‒
|
109
|
||||||
2033
|
‒
|
4,681
|
||||||
2034
|
‒
|
4,851
|
||||||
2035
|
‒
|
2,616
|
||||||
2036
|
‒
|
8,528
|
||||||
$
|
45,199
|
$
|
55,169
|
(1)
|
Undistributed profits of its foreign subsidiaries will not be distributed in the foreseeable future; and
|
(2)
|
Undistributed profits of its domestic subsidiaries will not be taxable when distributed.
|
19
|
Earnings per Share
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Basic weighted average number of shares outstanding (000's)
|
53,863
|
56,804
|
60,329
|
|||||||||
Plus dilutive effect of (000's):
|
||||||||||||
Restricted share units
|
675
|
549
|
574
|
|||||||||
Deferred share units
|
131
|
104
|
103
|
|||||||||
Stock options
|
‒
|
‒
|
9
|
|||||||||
Diluted weighted average number of shares outstanding (000's)
|
54,669
|
57,457
|
61,015
|
|||||||||
Stock awards excluded from the calculation of the diluted weighted average number of shares outstanding because their exercise price was greater than the average market price of the common shares (000's)
|
75
|
57
|
77
|
20
|
Segment Information
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Products
|
$
|
205,371
|
$
|
193,427
|
$
|
201,724
|
||||||
Services
|
27,212
|
28,662
|
29,082
|
|||||||||
$
|
232,583
|
$
|
222,089
|
$
|
230,806
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
United States
|
$
|
95,388
|
$
|
82,227
|
$
|
83,172
|
||||||
Canada
|
18,027
|
19,722
|
19,482
|
|||||||||
Other
|
14,129
|
17,547
|
19,195
|
|||||||||
Americas
|
127,544
|
119,496
|
121,849
|
|||||||||
United Kingdom
|
11,032
|
9,151
|
12,736
|
|||||||||
Other
|
46,140
|
48,123
|
51,243
|
|||||||||
Europe, Middle-East and Africa
|
57,172
|
57,274
|
63,979
|
|||||||||
China
|
25,281
|
21,526
|
22,468
|
|||||||||
Other
|
22,586
|
23,793
|
22,510
|
|||||||||
Asia-Pacific
|
47,867
|
45,319
|
44,978
|
|||||||||
$
|
232,583
|
$
|
222,089
|
$
|
230,806
|
As at August 31, 2016
|
As at August 31, 2015
|
|||||||||||||||||||||||
Property,
plant and equipment |
Intangible
assets |
Goodwill
|
Property,
plant and equipment |
Intangible
assets |
Goodwill
|
|||||||||||||||||||
Canada
|
$
|
27,048
|
$
|
1,330
|
$
|
–
|
$
|
27,174
|
$
|
1,310
|
$
|
–
|
||||||||||||
United States
|
1,174
|
1,637
|
13,265
|
948
|
1,255
|
13,224
|
||||||||||||||||||
Finland
|
572
|
354
|
8,663
|
295
|
1,433
|
8,636
|
||||||||||||||||||
India
|
3,602
|
37
|
–
|
4,011
|
65
|
–
|
||||||||||||||||||
China
|
2,657
|
33
|
–
|
2,500
|
30
|
–
|
||||||||||||||||||
Other
|
925
|
–
|
–
|
767
|
3
|
–
|
||||||||||||||||||
$
|
35,978
|
$
|
3,391
|
$
|
21,928
|
$
|
35,695
|
$
|
4,096
|
$
|
21,860
|
21
|
Subsequent Event
|
Consolidated statements of earnings data (1):
|
2016
|
2015
|
2014
|
2016
|
2015
|
2014
|
||||||||||||||||||
Sales
|
$
|
232,583
|
$
|
222,089
|
$
|
230,806
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
||||||||||||
Cost of sales (2)
|
87,066
|
85,039
|
86,836
|
37.4
|
38.3
|
37.6
|
||||||||||||||||||
Selling and administrative (3)
|
82,169
|
82,200
|
86,429
|
35.3
|
37.0
|
37.4
|
||||||||||||||||||
Net research and development
|
42,687
|
44,003
|
44,846
|
18.4
|
19.8
|
19.4
|
||||||||||||||||||
Depreciation of property, plant and equipment
|
3,814
|
4,835
|
4,995
|
1.6
|
2.2
|
2.2
|
||||||||||||||||||
Amortization of intangible assets
|
1,172
|
2,883
|
4,398
|
0.5
|
1.3
|
1.9
|
||||||||||||||||||
Interest and other income
|
(828
|
)
|
(155
|
)
|
(326
|
)
|
(0.4
|
)
|
(0.1
|
)
|
(0.1
|
)
|
||||||||||||
Foreign exchange gain
|
(161
|
)
|
(7,212
|
)
|
(1,634
|
)
|
–
|
(3.2
|
)
|
(0.7
|
)
|
|||||||||||||
Unusual charge (3)
|
–
|
603
|
720
|
–
|
0.3
|
0.3
|
||||||||||||||||||
Earnings before income taxes
|
16,664
|
9,893
|
4,542
|
7.2
|
4.4
|
2.0
|
||||||||||||||||||
Income taxes
|
7,764
|
5,036
|
4,286
|
3.4
|
2.2
|
1.9
|
||||||||||||||||||
Net earnings for the year
|
$
|
8,900
|
$
|
4,857
|
$
|
256
|
3.8
|
%
|
2.2
|
%
|
0.1
|
%
|
||||||||||||
Basic net earnings per share
|
$
|
0.17
|
$
|
0.09
|
$
|
0.00
|
||||||||||||||||||
Diluted net earnings per share
|
$
|
0.16
|
$
|
0.08
|
$
|
0.00
|
||||||||||||||||||
Other selected information:
|
||||||||||||||||||||||||
Gross margin before depreciation and amortization (4)
|
$
|
145,517
|
$
|
137,050
|
$
|
143,970
|
62.6
|
%
|
61.7
|
%
|
62.4
|
%
|
||||||||||||
Research and development data:
|
||||||||||||||||||||||||
Gross research and development
|
$
|
47,875
|
$
|
50,148
|
$
|
52,423
|
20.6
|
%
|
22.6
|
%
|
22.7
|
%
|
||||||||||||
Net research and development
|
$
|
42,687
|
$
|
44,003
|
$
|
44,846
|
18.4
|
%
|
19.8
|
%
|
19.4
|
%
|
||||||||||||
Restructuring charges included in:
|
||||||||||||||||||||||||
Cost of sales
|
$
|
–
|
$
|
290
|
$
|
–
|
–
|
%
|
0.1
|
%
|
–
|
%
|
||||||||||||
Selling and administrative expenses
|
$
|
–
|
$
|
586
|
$
|
–
|
–
|
%
|
0.3
|
%
|
–
|
%
|
||||||||||||
Net research and development expenses
|
$
|
–
|
$
|
761
|
$
|
–
|
–
|
%
|
0.3
|
%
|
–
|
%
|
||||||||||||
Adjusted EBITDA (4)
|
$
|
22,039
|
$
|
13,779
|
$
|
14,391
|
9.5
|
%
|
6.2
|
%
|
6.2
|
%
|
||||||||||||
Consolidated balance sheets data (1):
|
||||||||||||||||||||||||
Total assets
|
$
|
237,793
|
$
|
217,478
|
$
|
276,948
|
(1)
|
Consolidated statements of earnings and balance sheets data has been derived from our consolidated financial statements prepared according with IFRS, as issued by the IASB, except for non-IFRS measures (4).
|
(2)
|
The cost of sales is exclusive of depreciation and amortization, shown separately.
|
(3)
|
Selling and administrative is exclusive of unusual charge, shown separately, which represents bad debt expenses arising from the revision (see Note 1 to the consolidated financial statements included in this Annual Report on Form 20-F/A).
|
(4)
|
Refer to page 67 for non-IFRS measures.
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Physical-layer product line
|
$
|
151,910
|
$
|
144,060
|
$
|
132,097
|
||||||
Protocol-layer product line
|
83,324
|
80,591
|
99,618
|
|||||||||
235,234
|
224,651
|
231,715
|
||||||||||
Foreign exchange losses on forward exchange contracts
|
(2,651
|
)
|
(2,562
|
)
|
(909
|
)
|
||||||
Total sales
|
$
|
232,583
|
$
|
222,089
|
$
|
230,806
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Physical-layer product line
|
$
|
155,320
|
$
|
144,673
|
$
|
137,166
|
||||||
Protocol-layer product line
|
87,631
|
80,948
|
104,148
|
|||||||||
242,951
|
225,621
|
241,314
|
||||||||||
Foreign exchange losses on forward exchange contracts
|
(2,651
|
)
|
(2,562
|
)
|
(909
|
)
|
||||||
Total bookings
|
$
|
240,300
|
$
|
223,059
|
$
|
240,405
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
Americas
|
55
|
%
|
54
|
%
|
53
|
%
|
||||||
EMEA
|
25
|
26
|
28
|
|||||||||
APAC
|
20
|
20
|
19
|
|||||||||
100
|
%
|
100
|
%
|
100
|
%
|
Expiry dates
|
Contractual
amounts
|
Weighted average
contractual
forward rates
|
||||||
September 2016 to August 2017
|
$
|
22,200,000
|
1.2784
|
|||||
September 2017 to August 2018
|
9,900,000
|
1.3367
|
||||||
September 2018 to December 2018
|
1,900,000
|
1.3639
|
||||||
Total
|
$
|
34,000,000
|
1.3002
|
Expiry dates
|
Contractual
amounts
|
Weighted average
contractual
forward rate
|
||||||
September 2016 to August 2017
|
$
|
3,800,000
|
70.92
|
(a)
|
Determination of functional currency
|
(b)
|
Determination of cash generating units and allocation of goodwill
|
(a)
|
Inventories
|
(b)
|
Income taxes
|
(c)
|
Tax credits recoverable
|
(d)
|
Impairment of non-financial assets
|
EXFO CGU
|
$
|
8,663,000
|
|||
Brix CGU
|
13,265,000
|
||||
Total
|
$
|
21,928,000
|
Years ended August 31,
|
||||||||||||
2016
|
2015
|
2014
|
||||||||||
IFRS net earnings for the year
|
$
|
8,900
|
$
|
4,857
|
$
|
256
|
||||||
Add (deduct):
|
||||||||||||
Depreciation of property, plant and equipment
|
3,814
|
4,835
|
4,995
|
|||||||||
Amortization of intangible assets
|
1,172
|
2,883
|
4,398
|
|||||||||
Interest and other income
|
(828
|
)
|
(155
|
)
|
(326
|
)
|
||||||
Income taxes
|
7,764
|
5,036
|
4,286
|
|||||||||
Restructuring charges
|
–
|
1,637
|
–
|
|||||||||
Unusual charge (1)
|
–
|
603
|
720
|
|||||||||
Stock-based compensation costs
|
1,378
|
1,295
|
1,696
|
|||||||||
Foreign exchange gain
|
(161
|
)
|
(7,212
|
)
|
(1,634
|
)
|
||||||
Adjusted EBITDA for the year
|
$
|
22,039
|
$
|
13,779
|
$
|
14,391
|
||||||
Adjusted EBITDA in percentage of total sales
|
9.5
|
%
|
6.2
|
%
|
6.2
|
%
|
(1)
|
We have amended the calculation of adjusted EBITDA to include an adjustment for the unusual charge associated with bad debt expense, as described in Note 1, Revision to Consolidated Financial Statements, to our consolidated financial statements on the basis that the charge is not considered typical for our historical or future operating performance.
|
1st quarter
|
2nd quarter
|
3rd quarter
|
4th quarter
|
Year ended
August 31, |
||||||||||||||||
2016
|
||||||||||||||||||||
Sales
|
$
|
55,232
|
$
|
53,597
|
$
|
60,896
|
$
|
62,858
|
$
|
232,583
|
||||||||||
Cost of sales (2)
|
$
|
20,137
|
$
|
18,904
|
$
|
23,880
|
$
|
24,145
|
$
|
87,066
|
||||||||||
Net earnings
|
$
|
1,766
|
$
|
3,963
|
$
|
919
|
$
|
2,252
|
$
|
8,900
|
||||||||||
Basic net earnings per share (3)
|
$
|
0.03
|
$
|
0.07
|
$
|
0.02
|
$
|
0.04
|
$
|
0.17
|
||||||||||
Diluted net earnings per share
|
$
|
0.03
|
$
|
0.07
|
$
|
0.02
|
$
|
0.04
|
$
|
0.16
|
1st quarter
|
2nd quarter
|
3rd quarter
|
4th quarter
|
Year ended
August 31, |
||||||||||||||||
2015
|
||||||||||||||||||||
Sales
|
$
|
56,724
|
$
|
50,990
|
$
|
57,781
|
$
|
56,594
|
$
|
222,089
|
||||||||||
Cost of sales (2)
|
$
|
21,237
|
$
|
19,546
|
$
|
22,281
|
$
|
21,975
|
$
|
85,039
|
||||||||||
Net earnings
|
$
|
1,481
|
$
|
931
|
$
|
563
|
$
|
1,882
|
$
|
4,857
|
||||||||||
Basic net earnings per share (3)
|
$
|
0.02
|
$
|
0.02
|
$
|
0.01
|
$
|
0.03
|
$
|
0.09
|
||||||||||
Diluted net earnings per share
|
$
|
0.02
|
$
|
0.02
|
$
|
0.01
|
$
|
0.03
|
$
|
0.08
|
(1)
|
Quarterly financial information has been derived from our unaudited interim condensed financial statements, which are prepared in accordance with the IFRS, as issued by the IASB applicable to the preparation of interim financial statements, including IAS 34, "Interim Financial Reporting". The presentation currency is the US dollars, which differs from the functional currency of the company (Canadian dollar).
|
(2)
|
The cost of sales is exclusive of depreciation and amortization.
|
(3)
|
Per share data is calculated independently for each quarter presented. Therefore, the sum of this quarterly information does not equal the corresponding annual information.
|
|
|
1.
|
to receive the consolidated financial statements of the Corporation for the financial year ended August 31, 2016, and the Auditor's report thereon;
|
2.
|
to elect Directors of the Corporation;
|
3.
|
to appoint PricewaterhouseCoopers LLP as auditors and to authorize the Audit Committee to fix their remuneration;
|
4.
|
to transact such further or other business as may properly come before the Meeting or any adjournment or adjournments thereof.
|
|
|
Under Canadian Securities Law, you are entitled to receive certain investor documents. If you wish to receive such material, please tick the applicable boxes below. You may also go to CST website www.canstockta.com/financialstatements and input code 1629a..
q I would like to receive quarterly financial statements
q I do not want to receive annual financial statements
q I would like to receive future mailings by email at ______________________
I/We authorize you to act in accordance with my/our instructions set out above. I/We hereby revoke any proxy previously given with respect to the Meeting. If no voting instructions are indicated above, this Proxy will be voted FOR a matter by Management's appointees or, if you appoint another proxyholder, as that other proxyholder sees fit. On any amendments or variations proposed or any new business properly submitted before the Meeting, I/We authorize you to vote as you see fit.
________________________________________________ __________________
Signature(s) Date
Please sign exactly as your name(s) appear on this proxy. Please see reverse for instructions. All proxies must be received by January 19th, 2017 at 5:00 p.m. (Eastern time).
|
|||||
I/We, being holder(s) of subordinate voting shares of EXFO Inc. (the "Company"), hereby appoint: Germain Lamonde, President and Chief Executive Officer, or, failing him, Pierre Plamondon, Vice-President, Finance and Chief Financial Officer OR
__________________________________________________________________________________________
Print the name of the person you are appointing if this person is someone other than the individuals listed above
as proxy of the undersigned, to attend, act and vote on behalf of the undersigned in accordance with the below direction (or if no directions have been given, as the proxy sees fit) on all the following matters and any other matter that may properly come before the Annual Meeting of Shareholders of the Company to be held at 9:00 a.m. (Toronto Time) on January 11, 2017, at the St. Andrew's Club & Conference Centre, 150 King Street West, 27th Floor, Caledonia Room, Toronto, Ontario, Canada (the "Meeting"), and at any and all adjournments or postponements thereof in the same manner, to the same extent and with the same powers as if the undersigned were personally present, with full power of substitution.
|
|||||||
Management recommends voting FOR Resolutions 1 and 2. Please use a dark black pencil or pen.
|
|||||||
1. Election of Directors
|
FOR
|
WITHHOLD
|
|||||
1. Pierre-Paul Allard
|
☐
|
☐
|
|||||
2. François Côté
|
☐
|
☐
|
|||||
3. Germain Lamonde
|
☐
|
☐
|
|||||
4. Angela Logothetis
|
☐
|
☐
|
|||||
5. Claude Séguin
|
☐
|
☐
|
|||||
6. Randy E. Tornes
|
☐
|
☐
|
|||||
2. Appointment of Auditors
|
FOR
|
WITHHOLD
|
|||||
Appointment of PricewaterhouseCoopers LLP
as Auditors
|
☐
|
☐
|
|||||
Control Number
|
How to Vote
|
|||
Proxy Form – Annual Meeting of Shareholders of EXFO Inc. to be held on January 11, 2017 (the "Meeting")
Notes to Proxy
|
INTERNET
· Go to www.cstvotemyproxy.com
· Cast your vote online
· View Meeting documents
|
TELEPHONE
Use any touch-tone phone, call toll free in Canada and United States 1-888-489-7352 and follow the voice instructions
|
|
1. This proxy must be signed by a holder or his or her attorney duly authorized in writing. If you are an individual, please sign exactly as your name appears on this proxy. If the holder is a corporation, a duly authorized officer or attorney of the corporation must sign this proxy, and if the corporation has a corporate seal, its corporate seal should be affixed.
|
To vote using your smartphone,
please scan this QR Code è |
||
2. If the securities are registered in the name of an executor, administrator or trustee, please sign exactly as your name appears on this proxy. If the securities are registered in the name of a deceased or other holder, the proxy must be signed by the legal representative with his or her name printed below his or her signature, and evidence of authority to sign on behalf of the deceased or other holder must be attached to this proxy.
|
To vote by telephone or Internet you will need your control number. If you vote by Internet or telephone, do not return this proxy.
MAIL, FAX or EMAIL
|
||
3. Some holders may own securities as both a registered and a beneficial holder; in which case you may receive more than one Circular and will need to vote separately as a registered and beneficial holder. Beneficial holders may be forwarded either a form of proxy already signed by the intermediary or a voting instruction form to allow them to direct the voting of securities they beneficially own. Beneficial holders should follow instructions for voting conveyed to them by their intermediaries.
|
· Complete and return your signed proxy in the envelope provided or send to:
CST Trust Company
P.O. Box 721 Agincourt, ON M1S 0A1 |
||
4. If a security is held by two or more individuals, any one of them present or represented by proxy at the Meeting may, in the absence of the other or others, vote at the Meeting. However, if one or more of them are present or represented by proxy, they must vote together the number of securities indicated on the proxy.
|
· You may alternatively fax your proxy to 416-368-2502 or toll free in Canada and the United States to 1-866-781-3111 or scan and email to proxy@canstockta.com
|
||
All holders should refer to the Proxy Circular for further information regarding completion and use of this proxy and other information pertaining to the Meeting.
This proxy is solicited by and on behalf of Management of the Company.
|
An undated proxy is deemed to be dated on the day it was received by CST.
If you wish to receive investor documents electronically in future, please visit www.canstockta.com/electronicdelivery to enrol.
|
||
All proxies must be received by January 10, 2017 at 5:00 p.m. (Eastern time).
|
Name of Shareholder
|
Number of
Subordinate Voting Shares |
Percentage of Voting
Rights Attached to All Subordinate Voting Shares |
Number of
Multiple Voting Shares (1) |
Percentage of Voting
Rights Attached to All Multiple Voting Shares |
Percentage of Voting
Rights Attached to All Subordinate and Multiple Voting Shares |
|||
Germain Lamonde
|
4,316,247
|
(2)
|
18.93%
|
31,643,000
|
(3)
|
100%
|
94.55%
|
|
EdgePoint Investment Group, Inc.
|
4,193,500
|
18.39%
|
–
|
–
|
1.24%
|
(1)
|
The holder of Multiple Voting Shares is entitled to ten (10) votes for each share.
|
(2)
|
Mr. Lamonde exercises control over 4,000,000 Subordinate Voting Shares through G. Lamonde Investissements Financiers Inc., a company controlled by Mr. Lamonde.
|
(3)
|
Mr. Lamonde exercises control over this number of Multiple Voting Shares through G. Lamonde Investissements Financiers Inc., a company controlled by Mr. Lamonde and through Fiducie Germain Lamonde, a family trust for the benefit of Mr. Lamonde's family.
|
GERMAIN LAMONDE
|
||
|
St-Augustin-de-Desmaures,
Quebec, Canada Director since September 1985
Not Independent (Management)
Principal Occupation:
Chairman of the Board of Directors, President and Chief Executive Officer of the Corporation |
Germain Lamonde, a founder of EXFO, has been President and Chief Executive Officer of EXFO since its inception in 1985. He has also been Chairman of the Board since EXFO went public in 2000. Responsible for the overall management and strategic direction of EXFO, Mr. Lamonde has grown the company from the ground up into a global leader in the test, service assurance and analytics markets. Mr. Lamonde has served on the board of directors of several organizations such as the Canadian Institute for Photonic Innovations, the POLE QCA Economic Development Corporation, the National Optics Institute of Canada (INO) and Université Laval in Quebec City, to name a few. Mr. Lamonde has also been involved in numerous charity organizations such as United Way and served as honorary President for the Leucan Shaved Head initiative for the Quebec City Region. Germain Lamonde holds a bachelor's degree in engineering physics from the University of Montreal's School of Engineering (École Polytechnique), a master's degree in optics from Université Laval, and is also a graduate of the Ivey Executive Management Program offered by the University of Western Ontario.
|
Board/Committee Membership
|
Attendance (1)
|
Board Memberships of Another Reporting Issuer
|
||||
Chairman of the Board of Directors
|
6/6
|
100%
|
–
|
|||
Securities Held
|
||||||
As at
|
Subordinate
Voting Shares (#) |
Multiple Voting
Shares (#) |
RSUs (#)
|
Total Shares (2)
and RSUs (#) |
Total Market Value (3)
of Shares (2) and RSUs (US$) |
|
August 31, 2016
|
4,316,247 (4)
|
31,643,000 (5)
|
53,261
|
36,012,508
|
118,841,276
|
(1)
|
From September 1, 2015 until November 1, 2016, Mr. Lamonde attended five (5) board meetings in person and one (1) board meeting by telephone.
|
(2)
|
Includes both Subordinate Voting Shares and Multiple Voting Shares.
|
(3)
|
The value of unvested RSUs at the financial year-end is the market value of the Subordinate Voting Shares on August 31, 2016, which was US$3.30 (CA$4.33). The market value of the Subordinate Voting Shares and Multiple Voting Shares was calculated by using the highest of the closing prices of the Subordinate Voting Shares on the Toronto Stock Exchange and on the NASDAQ National Market on August 31, 2016 using the noon buying rate of the Bank of Canada to convert either the NASDAQ National Market closing price to Canadian dollars or the Toronto Stock Exchange closing price to United States dollars as required. The actual gains on vesting of RSUs will depend on the value of the Subordinate Voting Shares on the date of vesting. There can be no assurance that these values will be realized.
|
(4)
|
Mr. Lamonde exercises control over 4,000,000 of Subordinate Voting Shares through G. Lamonde Investissements Financiers Inc., a company controlled by Mr. Lamonde.
|
(5)
|
Mr. Lamonde exercises control over this number of Multiple Voting Shares through G. Lamonde Investissements Financiers Inc., a company controlled by Mr. Lamonde and through Fiducie Germain Lamonde, a family trust for the benefit of Mr. Lamonde's family.
|
PIERRE-PAUL ALLARD
|
||||
|
Pleasanton, California, USA
Director since September 2008
Independent
Principal Occupation:
Senior Vice-President, Worldwide Sales and
President Global Field Operations, Check Point Software Technologies Inc. (1) |
Pierre-Paul Allard was appointed a member of our Board of Directors in September 2008 and has been a board member of many other technology companies in Canada and in the US. Mr. Allard is Senior Vice-President, Worldwide Sales and President Global Field Operations at Check Point Software Technologies Inc. As Chief Revenue Officer, Mr. Allard is responsible for all go-to-market at Check Point. Prior to joining Check Point in July 2016, Mr. Allard led the go to market and sales teams at Avaya Inc. for 4 years. Prior to this, he worked for nineteen (19) years at Cisco Systems, Inc., where he most recently held the position of Vice-President, Sales and Operations, Global Enterprise. Previously, Mr. Allard was President of Cisco Systems Canada, and before that he held various management roles at IBM Canada for twelve (12) years. In 2002, Mr. Allard co-chaired the Canadian e-Business Initiative, a private-public partnership aiming to measure the role e-Business plays in increasing productivity levels, job creation and competitive position. In 1998, he was the laureate of the Arista-Sun life Award, for Top Young Entrepreneur in Large Enterprise, conferred by the Montreal Chamber of Commerce. In 2003, he received the Queen's Golden Jubilee Medal, which highlights significant contributions to Canada. In the same year, he was also awarded the prestigious Trudeau Medal from the University of Ottawa, Telfer School of Management. Pierre-Paul Allard holds a bachelor's and masters' degree in business administration from the University of Ottawa, Canada.
|
||
Board/Committee Membership
|
Attendance (2)
|
Board Memberships of Another Reporting Issuer
|
||
Board of Directors
Audit Committee Human Resources Committee Independent Board of Directors |
5/6
4/5 4/5 4/5 |
83%
80% 80% 80% |
–
|
Securities Held
|
||||
As at
|
Subordinate
Voting Shares (#) |
DSUs (#)
|
Total Shares
and DSUs (#) |
Total Market Value (3)
of Shares (4) and DSUs (US$) |
August 31, 2016
|
8,000
|
48,883
|
56,883
|
187,714
|
(1)
|
Check Point Software Technologies Inc. is an international provider of software products for IT security, including network security, endpoint security, data security and security management
|
(2)
|
From September 1, 2015 until November 1, 2016, Mr. Allard attended four (4) board meetings in person and one (1) board meeting by telephone.
|
(3)
|
The value of unvested DSUs at the financial year-end is the market value of the Subordinate Voting Shares on August 31, 2016, which was US$3.30 (CA$4.33). The market value of the Subordinate Voting Shares was calculated by using the highest of the closing prices of the Subordinate Voting Shares on the Toronto Stock Exchange and on the NASDAQ National Market on August 31, 2016 using the noon buying rate of the Bank of Canada to convert either the NASDAQ National Market closing price to Canadian dollars or the Toronto Stock Exchange closing price to United States dollars as required. The actual gains on vesting of DSUs will depend on the value of the Subordinate Voting Shares on the date of vesting. There can be no assurance that these values will be realized.
|
(4)
|
Refers to Subordinate Voting Shares.
|
FRANÇOIS CÔTÉ
|
||||
|
Montreal, Quebec, Canada
Director since January 2015
Lead Director
Independent
Principal Occupation:
Director |
François Côté is a director as a full-time occupation, for corporations in the public, private and non-profit sectors, bringing his expertise in strategy, M&A, governance and passion for growth. Mr. Côté held a variety of executive positions at Bell Canada prior to becoming President and Chief Executive Officer of Emergis. Following the acquisition of Emergis by TELUS in January 2008, he was appointed President of TELUS Quebec, TELUS Health and TELUS Ventures. In this role, Mr. Côté was responsible for broadening TELUS Quebec's presence and driving the company's national health strategy through timely investments in information technology and innovative wireless solutions. Mr. Côté holds a Bachelor's degree in Industrial Relations from Laval University. In 2007, he was named Entrepreneur of the Year by Ernst & Young, in the Corporate Restructuring category for the province of Quebec. Mr. Côté serves on the boards of Alithya and Lumenpulse Inc. (LMP) as well as the Advisory Board of the McGill Centre for the Convergence of Health and Economics (MCCHE). He is also Chairman of the Board for Norda Stelo, Vice-President of the Board of the Foundation Dr. Julien and Board member of the Fondation Martin Matte. In June 2013, Mr. Côté was named Honourary Lieutenant-Colonel of the Canadian Armed Forces' 34th Signal Regiment.
|
||
Board/Committee Membership
|
Attendance (2)
|
Board Memberships of Another Reporting Issuer
|
||
Board of Directors
Audit Committee Human Resources Committee Independent Board of Directors |
5/6
5/5 5/5 5/5 |
83%
100% 100% 100% |
Lumenpulse Inc.
|
Securities Held
|
||||
As at
|
Subordinate
Voting Shares (#) |
DSUs (#)
|
Total Shares
and DSUs (#) |
Total Market Value (3)
of Shares (4) and DSUs (US$) |
August 31, 2016
|
3,000
|
10,809
|
13,809
|
45,570
|
(1)
|
From September 1, 2015 until November 1, 2016, Mr. Côté attended five (5) board meetings in person and no board meeting by telephone.
|
(2)
|
The value of unvested DSUs at the financial year-end is the market value of the Subordinate Voting Shares on August 31, 2016, which was US$3.30 (CA$4.33). The market value of the Subordinate Voting Shares was calculated by using the highest of the closing prices of the Subordinate Voting Shares on the Toronto Stock Exchange and on the NASDAQ National Market on August 31, 2016 using the noon buying rate of the Bank of Canada to convert either the NASDAQ National Market closing price to Canadian dollars or the Toronto Stock Exchange closing price to United States dollars as required. The actual gains on vesting of DSUs will depend on the value of the Subordinate Voting Shares on the date of vesting. There can be no assurance that these values will be realized.
|
(3)
|
Refers to Subordinate Voting Shares.
|
ANGELA LOGOTHETIS
|
||||
|
Bath
United Kingdom Proposed nominee for Director to the
January 2017 shareholders' meeting
Independent
Principal Occupation:
Vice-President, Head of Technology and Services Amdocs (1) |
Angela Logothetis has more than 25 years of international experience in the telecommunications industry. She has been strategically engaged in the industry's major network transformations. Ms. Logothetis has an outstanding software pedigree having worked for market-leading software companies including Amdocs, Cramer, PricewaterhouseCoopers and Accenture as well as start-up software companies Clarity and Time Quantum Technology. She has held senior leadership positions in ANZ, APAC and EMEA and has held global responsibility for the past 10 years. Ms. Logothetis is the Head of Network Strategy, Technology and Services for Amdocs. Amdocs is the market leader in customer experience software solutions and services for the world's largest communications, entertainment and media service providers. Ms. Logothetis has held several senior leadership positions at Amdocs including Head of OSS Product and Technology, Vice-President of OSS Product Management and Executive Site Lead for Amdocs Bath. She has chaired high-caliber software forums in Amdocs including the Divisional Leadership Team, the Technical Advisory Council, and has served as an executive on the Product Business Management Team and the Product Leadership Forum. Ms. Logothetis holds a Bachelor of Science degree, with first class honors, in Business Information Technology from the University of NSW, Australia. She completed dual majors in accountancy and information technology.
|
||
Board/Committee Membership
|
Attendance (2)
|
Board Memberships of Another Reporting Issuer
|
||
Board of Directors
Audit Committee Human Resources Committee Independent Board of Directors |
N/A
N/A N/A N/A |
N/A
N/A N/A N/A |
–
|
Securities Held
|
||||
As at
|
Subordinate
Voting Shares (#) |
DSUs (#)
|
Total Shares
and DSUs (#) |
Total Market Value (3)
of Shares (4) and DSUs (US$) |
August 31, 2016
|
–
|
–
|
–
|
–
|
(1)
|
Amdocs is a market leader in software solutions and services for communications, media and entertainment service providers.
|
(2)
|
Ms. Logothetis, if elected, will join our Board of Directors on January 11, 2017. Hence, from September 1, 2015 until November 1, 2016, Ms. Logothetis did not attend any meetings.
|
CLAUDE SÉGUIN
|
||||
|
Westmount, Quebec,
Canada Director since February 2013
Independent
Principal Occupation:
Special Advisor to the Founder and Executive Chairman, CGI Group Inc. (1) |
Claude Séguin was appointed a member of EXFO's Board of Directors in February 2013. He brings to EXFO nearly forty (40) years of corporate, financial, executive and provincial government experience gained through senior management positions in major corporations and government departments. Mr. Séguin is currently Special advisor to the Founder and Executive Chairman at CGI Group Inc., a global leader in information technology and business process services. He was, until October 2016, Senior Vice-President, Corporate Development and Strategic Investments. In this position, he was responsible for all merger and acquisition activities. Prior to joining CGI in 2003, he served as President of CDP Capital—Private Equity, and prior to this position, he served as Teleglobe Inc.'s Executive Vice-President, Finance and Chief Financial Officer, a position that he held from 1992 to 2000. Mr. Séguin also has extensive senior-level government experience, having served as Deputy Finance Minister of the Province of Québec from 1987 to 1992, in addition to Assistant Deputy Finance Minister. Prior to that, he has been Director of Planning and Assistant Director of Social Programs at the Province of Quebec Treasury Board. Mr. Séguin is a member of the boards of HEC-Montréal and Centraide of Greater Montreal Foundation as well as being Chairman of the Board of Finance – Montreal, an organization regrouping financial institutions in the Province of Quebec. Claude Séguin graduated from HEC-Montréal and earned a master's and a Ph.D. in public administration from Syracuse University in New York State. He also followed the Advanced Management Program at Harvard Business School.
|
||
Board/Committee Membership
|
Attendance (2)
|
Board Memberships of Another Reporting Issuer
|
||
Board of Directors
Audit Committee Human Resources Committee Independent Board of Directors |
6/6
5/5 5/5 5/5 |
100%
100% 100% 100% |
–
|
Securities Held
|
||||
As at
|
Subordinate
Voting Shares (#) |
DSUs (#)
|
Total Shares
and DSUs (#) |
Total Market Value (3)
of Shares (4) and DSUs (US$) |
August 31, 2016
|
–
|
21,755
|
21,755
|
71,792
|
(1)
|
CGI Group Inc. is an information technology consulting, systems integration, outsourcing and solutions company.
|
(2)
|
From September 1, 2015 until November 1, 2016, Mr. Séguin attended five (5) board meetings in person and one (1) board meeting by telephone.
|
(3)
|
The value of unvested DSUs at the financial year-end is the market value of the Subordinate Voting Shares on August 31, 2016, which was US$3.30 (CA$4.33). The market value of the Subordinate Voting Shares was calculated by using the highest of the closing prices of the Subordinate Voting Shares on the Toronto Stock Exchange and on the NASDAQ National Market on August 31, 2016 using the noon buying rate of the Bank of Canada to convert either the NASDAQ National Market closing price to Canadian dollars or the Toronto Stock Exchange closing price to United States dollars as required. The actual gains on vesting of DSUs will depend on the value of the Subordinate Voting Shares on the date of vesting. There can be no assurance that these values will be realized.
|
(4)
|
Refers to Subordinate Voting Shares.
|
RANDY E. TORNES
|
||||
|
Frisco, Texas, USA
Director since February 2013
Independent
Principal Occupation:
Vice-President, Strategic Alliances, Juniper Networks (1)
|
Randy E. Tornes was appointed a member of EXFO's Board of Directors in February 2013. He brings to EXFO over thirty (30) years of telecommunications experience gained through senior management positions at leading network equipment manufacturers. Mr. Tornes is Vice-President, Strategic Alliances at Juniper Networks, a worldwide leader in high-performance networking and telecommunications equipment. Prior to his current role at Juniper, he was the Operating Area Leader for AT&T and responsible for all sales, service and support of Juniper products and services. Prior to joining Juniper Networks in May 2012, he spent two (2) years at Ericsson, where he was Vice-President Sales (AT&T account). Previous to that position, he worked for Nortel for twenty-six (26) years, holding various sales management positions, including Vice-President Sales, GSM Americas. Mr. Tornes also served as member of the Board of Governors at 3G Americas LLC. Randy E. Tornes holds a Bachelor of Science degree in business—organizational development and production and operations management, from the University of Colorado in Colorado Springs.
|
||
Board/Committee Membership
|
Attendance (2)
|
Board Memberships of Another Reporting Issuer
|
||
Board of Directors
Audit Committee Human Resources Committee Independent Board of Directors |
5/6
5/5 5/5 4/5 |
83%
100% 100% 80% |
–
|
Securities Held
|
||||
As at
|
Subordinate
Voting Shares (#) |
DSUs (#)
|
Total Shares
and DSUs (#) |
Total Market Value (3)
of Shares (4) and DSUs (US$) |
August 31, 2016
|
–
|
49,463
|
49,463
|
163,228
|
(1)
|
Juniper Networks is a manufacturer of networking equipment.
|
(2)
|
From September 1, 2015 until November 1, 2016, Mr. Tornes attended four (4) board meetings in person and one (1) board meeting by telephone.
|
(3)
|
The value of unvested DSUs at the financial year-end is the market value of the Subordinate Voting Shares on August 31, 2016, which was US$3.30 (CA$4.33). The market value of the Subordinate Voting Shares was calculated by using the highest of the closing prices of the Subordinate Voting Shares on the Toronto Stock Exchange and on the NASDAQ National Market on August 31, 2016 using the noon buying rate of the Bank of Canada to convert either the NASDAQ National Market closing price to Canadian dollars or the Toronto Stock Exchange closing price to United States dollars as required. The actual gains on vesting of DSUs will depend on the value of the Subordinate Voting Shares on the date of vesting. There can be no assurance that these values will be realized.
|
(4)
|
Refers to Subordinate Voting Shares.
|
a)
|
is, as at the date hereof, or has been, within ten (10) years before the date hereof, a director, chief executive officer or chief financial officer of any company that (i) was subject to an order that was issued while such individual was acting in the capacity as director, chief executive officer or chief financial officer, or (ii) was subject to an order that was issued after such individual ceased to be a director, chief executive officer or chief financial officer and which resulted from an event that occurred while that person was acting in the capacity as director, chief executive officer or chief financial officer;
|
b)
|
is, as at the date hereof, or has been within ten (10) years before the date hereof, a director or executive officer of any company that, while such individual was acting in that capacity, or within a year of that individual ceasing to act in that capacity, became bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency or was subject to or instituted any proceedings, arrangement or compromise with creditors or had a receiver, receiver manager or trustee appointed to hold its assets;
|
c)
|
has, within the ten (10) years before the date hereof, become bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency, or become subject to or instituted any proceedings, arrangement or compromise with creditors, or had a receiver, receiver manager or trustee appointed to hold his assets; or
|
d)
|
has been subject to (i) any penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory authority or has entered into a settlement agreement with a securities regulatory authority, or (ii) any other penalties or sanctions imposed by a court or regulatory body that would likely be considered important to a reasonable security holder in deciding whether to vote for such individual.
|
·
|
Mr. François Côté (Chairman)
|
·
|
Mr. Pierre-Paul Allard
|
·
|
Mr. Darryl Edwards
|
·
|
Mr. Claude Séguin
|
·
|
Mr. Randy E. Tornes
|
Meeting
|
Main Activities of the Human Resources Committee
|
|
October 7, 2015
|
●
|
Review of the Business Performance Measures results for the financial year ended August 31, 2015;
|
●
|
Review of the Business Performance Measures for the financial year started September 1, 2015;
|
|
●
|
Review of the Short-Term Incentive Plan results for the financial year ended August 31, 2015;
|
|
●
|
Review of the Short-Term Incentive Plan for the financial year started September 1, 2015;
|
|
●
|
Review of the proposed salary scales and salary increases for the year started September 1, 2015;
|
|
●
|
Review of the compensation plans of executive officers for the financial year started September 1, 2015 being the Base Salary, the Short-Term Incentive Plan and the stock-based compensation delivered through the Long-Term Incentive Plan;
|
|
●
|
Review and approval of the stock-based compensation plan for the sales force delivered through the Long-Term Incentive Plan for the financial year started September 1, 2015;
|
|
●
|
Review and approval of the quantum for the stock-based compensation plan for the performing employees delivered through the Long-Term Incentive Plan for the financial year started September 1, 2015;
|
|
●
|
Review and approval of the executive compensation section of the Management proxy circular for the financial year ended August 31, 2015;
|
|
●
|
Review and approval of the CEO objectives and compensation plan;
|
|
●
|
Review of the Risk Assessment of Executive Compensation disclosure obligations.
|
|
January 6, 2016
|
●
|
Review and approval of the Business Performance Measures for the financial year started September 1, 2015;
|
●
|
Review and approval of the Short-Term Incentive Plan of some executive officers for the financial year started September 1, 2015, including the CEO objectives;
|
|
●
|
Review of the Short-Term Incentive Plan results for the financial year ended August 31, 2015;
|
|
●
|
Review of the quarterly results under the Short-Term Incentive Plan for the financial year started September 1, 2015 and being part of the Short-Term Incentive Plan;
|
|
●
|
Review and approval of the stock-based compensation for performing employees delivered through the Long-Term Incentive Plan for the financial year started September 1, 2015;
|
|
●
|
Global Compensation Review;
|
|
●
|
Leadership program;
|
|
●
|
Talent Management.
|
|
March 29, 2016
|
●
|
Review of the quarterly results under the Short-Term Incentive Plan for the financial year started September 1, 2015 and being part of the Short-Term Incentive Plan;
|
●
|
Succession Planning;
|
|
●
|
Review and approval of the Short-Term Incentive Plan of some executive officers for the financial year started September 1, 2015;
|
|
●
|
Review of the Key Human Capital Initiatives;
|
|
●
|
Executive Compensation Review;
|
|
●
|
Leadership program;
|
|
●
|
Review of the selection criteria for Board Members;
|
|
●
|
Review of the Talent Management.
|
|
June 29, 2016
|
●
|
Review of the quarterly results under the Short-Term Incentive Plan for the financial year started September 1, 2015 and being part of the Short-Term Incentive Plan;
|
●
|
Review and approval of the Short-Term Incentive Plan of the remaining executive officers for the financial year started September 1, 2015;
|
|
●
|
Update on the Global Compensation Review;
|
|
●
|
Update on the Management Structure Review;
|
|
●
|
Update on the Talent Management Review;
|
|
●
|
Review of the Key Human Capital Initiatives.
|
|
October 12, 2016
|
●
|
Review of the Business Performance Measures results for the financial year ended August 31, 2016;
|
●
|
Review of the Business Performance Measures for the financial year started September 1, 2016;
|
|
●
|
Review of the Short-Term Incentive Plan results for the financial year ended August 31, 2016;
|
|
●
|
Update on the Short-Term Incentive Plan for the financial year started September 1, 2016;
|
|
●
|
Review of the proposed salary scales and salary increases for the year started September 1, 2016;
|
|
●
|
Review of the compensation plans of executive officers for the financial year started September 1, 2016 being the Base Salary, the Short-Term Incentive Plan and the stock-based compensation delivered through the Long-Term Incentive Plan;
|
|
●
|
Review and approval of the stock-based compensation plan for the sales force delivered through the Long-Term Incentive Plan for the financial year started September 1, 2016;
|
|
●
|
Review and approval of the quantum for the stock-based compensation plan for the performing employees delivered through the Long-Term Incentive Plan for the financial year started September 1, 2016;
|
|
●
|
Review and approval of the executive compensation section of the Management proxy circular for the financial year ended August 31, 2016;
|
|
●
|
Review and approval of the CEO objectives and compensation plan;
|
|
●
|
Review of the Risk Assessment of Executive Compensation disclosure obligations.
|
Type of Fee
|
Financial 2015 Fees
|
Percentage of
Financial 2015 Fees |
Financial 2016 Fees
|
Percentage of
Financial 2016 Fees |
||||
Executive Compensation - Related Fees
|
CA$0,00
|
0%
|
CA$28,734
|
28%
|
||||
All Other Fees
|
CA$115,333
|
100%
|
CA$175,202
|
72%
|
||||
Total
|
CA$115,333
|
100%
|
CA$203,936
|
100%
|
·
|
Canada executives: For the executives based in Canada, the Corporation used the following comparator group: 5N Plus Inc., ACCEO Solutions, AgJunction Inc, Atos IT Services and Solutions, Inc., Avigilon Corporation, Callian Technologies Ltd., Ciena, COM DEV International Ltd., Constellation Software inc., Evertz Technologies Ltd., GTECH, Open Text Corporation, Redline Communications Group Inc., Sandvine Corporation, Sierra Wireless Inc., Smart Technologies Inc., Vecima Networks Inc., Vidéotron Ltée and Wi-Lan Inc.
|
·
|
United States executives: For the executives based in the United States, the Corporation used the following comparator group: AMETEK, Avangate, BMC Software, CDK Global, Communications Systems, Crown Castle, Intelsat, Itron, Keysight Technologies, Laird Technologies, MTS Systems, Plexus, SAS Institute, SunGard Data Systems, Teradata, TomTom, Total System Services, Truphone, Verint Systems.
|
·
|
United Kingdom executives: For the executives based in the United Kingdom, the Corporation used the following comparator group: BAE Systems Applied Intelligence, COLT Telecom, Flextronics, Fujitsu, Irdeto, McCain Foods, PepsiCo, Premier Food Group, QinetiQ, Qualcomm, Rentokil Initial, Talk Talk Group, Viacom.
|
·
|
Asia executives: For the executives based in Asia, the Corporation used a broader comparator group, based on general industry data: A.Menarini Asia-Pacific, Abbott Laboratories, AbbVie, Accenture, ACE Asia Pacific Services, ACE Insurance, ACE Life Insurance Company Ltd, ACR Capital Holdings, AIA Company, Aimia, Alcatel-Lucent, Amazon.com, ANZ Banking Group, ASML, AstraZeneca, Avanade, Aviva Ltd, AXA Insurance Singapore, AXA Life Insurance Singapore, Bank of New York Mellon, Baxter, Beckman Coulter, Becton Dickinson, BHP Billiton, Bio-Rad Laboratories, Biosensors, BT Global Services, Cerebos Pacific Limited, Chubb Pacific Underwriting, Cigna, CommScope, DHL, DHL Express, DHL GBS, DHL Global Forwarding, DHL Mail, DHL Supply Chain, Discovery Communications, Experian, Federal Insurance Company, Fujitsu, GE Energy, GE Healthcare, General Electric, Great Eastern Life Insurance, Hap Seng Consolidated, HSBC Holdings, IHS Global, IMI, Ingenico, Intel, Intercontinental Hotels Group, International Flavors & Fragrances, ITT Corporation, Johnson & Johnson, Lexmark, Liberty Insurance, M1 Limited, Manulife, MasterCard, Merck KGaA, Microsoft, Molex, MSD International GMBH (Singapore Branch), National Australia Bank, NBC Universal, NCR, Overseas Assurance Corporation, Pfizer, Pramerica Financial Asia HQ, Proximus, Prudential Assurance Company, Prudential Services, QBE Insurance, Qualcomm, Reinsurance Group of America, RELX Group, Rio Tinto, Roche Pharmaceuticals, Sabre Holdings, Sealed Air, Smiths Group, Spirax Sarco, Standard Chartered Bank, StarHub, Starwood Hotels & Resorts, Straits Developments, Swiss Reinsurance International, Teva Pharmaceutical Industries, Thermo Fisher Scientific, Trayport, TUI, UBS, Unilever, United Overseas Bank, Verizon, Zurich Insurance Company, Zurich Life Insurance.
|
a)
|
Similar industry: Technology Hardware and Equipment, Telecommunications Equipment and Services or Software and Services; and
|
b)
|
Comparable in size: revenues under CA$1 billion. Only one publicly traded company had revenues above the equivalent of CA$1 billion. The compensation market comparison is done using the regression analysis which is a method to predict the "size-adjusted" competitive level of compensation to reflect the size of the Corporation in relation to that of the other companies of the reference group. This method mitigates the impact that larger companies may have on the competitive compensation levels for the Corporation.
|
·
|
Performance-based: Executive compensation levels reflect both the results of the Corporation and individual results based on specific quantitative and qualitative objectives established at the beginning of each financial year in keeping with the Corporation's long-term strategic objectives.
|
·
|
Aligned with shareholder interests: An important portion of incentive compensation for executives is composed of equity awards to ensure that executives are aligned with the principles of sustained long-term shareholder value growth.
|
·
|
Market competitive: Compensation of executives is designed to be externally competitive when compared against executives of comparable peer companies, and in consideration of the Corporation's results.
|
·
|
Individually equitable: Compensation levels are also designed to reflect individual factors such as scope of responsibility, experience, and performance against individual measures.
|
Name & Position
|
Annual Incentive Target as % of Base Salary
|
Germain Lamonde, CEO
|
65.0%
|
Philippe Morin, COO
|
50.0%
|
Pierre Plamondon, Vice-President, Finance and CFO
|
42.5%
|
Jon Bradley, Vice-President, Sales — EMEA
|
70.0%
|
Dana Yearian, Vice-President, Sales — Americas
|
89.0%
|
Base Salary
|
X
|
Annual Incentive Target (%)
|
X
|
Business Performance Measures (%)
|
X
|
Individual Performance Measures (%)
|
Business Performance Measures (1)
|
Weight
|
Result in % of the Weight
|
Result of the Metrics
|
|||
Consolidated revenues (2)
|
30%
|
17.85%
|
US$232.6 million
|
|||
Adjusted EBITDA (3)
|
45%
|
30.52%
|
US$22.0 million
|
|||
Quality (4)
|
15%
|
12.75%
|
95%
|
|||
Net Promoter Score (5)
|
5%
|
5.88%
|
70%
|
|||
On-time delivery (4)
|
5%
|
4.22%
|
96.5%
|
|||
Total
|
100%
|
71.22%
|
||||
(1)
|
The corporate Adjusted EBITDA result for the year must be positive (above 0) for the whole Business Performance Measure to trigger a payout. Adjusted EBITDA represents net earnings before interest, income taxes, depreciation and amortization, restructuring charges, stock-based compensation costs and foreign exchange gain.
|
(2)
|
For consolidated revenues metric, results will be based on the achievement from 25% to 125%, calculated on a pro-rated basis, from the revenues attained in the previous financial year (US$222.1 million) up to the target defined at the beginning of the financial year (US$252.5 million).
|
(3)
|
For Adjusted EBITDA metric, results will be based on the achievement from 25% to 125%, calculated on a pro-rated basis, from the Adjusted EBITDA attained in the previous financial year (US$13.8 million) up to the target defined at the beginning of the financial year (US$33.1 million).
|
(4)
|
For quality and on-time delivery metrics, results will range from nil to 100% of the weight upon attainment of a minimum threshold of 50% and 91.7%, respectively, up to the annual target defined at the beginning of the financial year and from 100% to 150% of the weight from such annual target to the maximum threshold of 125% and 99.7%, respectively.
|
(5)
|
For Net Promoter Score metrics, results will range from nil to 100% of the weight upon attainment of a minimum threshold of 45% up to the annual target defined at the beginning of the financial year and from 100% to 150% of the weight from such annual target to the maximum threshold of 72%.
|
Germain Lamonde, CEO
|
||||
Elements of Individual Performance Measures1
|
Weight
(from 0% to 160%) |
Result
(%) |
||
Financial objectives
|
||||
Corporate revenues
|
From 0% to 35%
|
25.70%
|
||
Corporate EBITDA
|
From 0% to 55%
|
17.85%
|
||
Strategic contribution
|
||||
Merger and Acquisition activities aiming towards a Solutions oriented company
|
From 0% to 20%
|
18.00%
|
||
Establishment and implementation of a strategic plan that will result in revenue growth in identified services and
products family
|
From 0% to 20%
|
15.50%
|
||
Customer Satisfaction
|
From 0% to 15%
|
11.63%
|
||
Employee Satisfaction
|
From 0% to 15%
|
13.50%
|
||
Total
|
102.18%
|
|||
Total of Business Performance Measures (71.22%) X Individual Performance Measures (102.18%)
|
72.77%
|
|||
(1)
|
If the minimum level of the Corporate EBITDA, as determined at the beginning of the financial year, is not achieved, payment of any variable compensation to the CEO will be at the discretion of the Human Resources Committee.
|
Philippe Morin, COO
|
||||
Elements of Individual Performance Measures
|
Weight
(from 0% to 150%) |
Result
(%) |
||
Financial objectives
|
Weight
|
From 0% to 70%
|
49.30%
|
|
Corporate EBITDA
|
40%
|
|||
Corporate revenues
|
30%
|
|||
Strategic contribution
|
Weight
|
From 0% to 80%
|
52.27%
|
|
Expending corporate revenues, profitability and positioning in selected strategic markets
|
30%
|
|||
Delivering the strategies and objectives under the NEO's responsibility as set forth in the Corporation's
strategic plan
|
30%
|
|||
Positioning and transforming the Corporation to allow significant growth in Corporate EBITDA
and revenues
|
20%
|
|||
Total
|
101.57%
|
|||
Total of Business Performance Measures (71.22%) X Individual Performance Measures (101.57%)
|
72.34%
|
Pierre Plamondon, Vice-President, Finance and CFO
|
||||
Elements of Individual Performance Measures
|
Weight
(from 0% to 150%) |
Result
(%) |
||
Financial objectives
|
Weight
|
From 0% to 70%
|
49.64%
|
|
Corporate EBITDA
|
40%
|
|||
Corporate revenues
|
30%
|
|||
Strategic contribution
|
Weight
|
From 0% to 80%
|
73.10%
|
|
Delivering the strategies and objectives under the NEO's responsibility as set forth in the
Corporation's strategic plan
|
30%
|
|||
Maintaining the highest standard and compliance in the Corporation's financial reporting; internal
controls and corporate governance; corporate development and risk management
|
30%
|
|||
Delivering a Strategic Contribution and Support in the Corporation's information technology
management, investors relations and legal services
|
20%
|
|||
Total
|
122.74%
|
|||
Total of Business Performance Measures (71.22%) X Individual Performance Measures (122.74%)
|
87.41%
|
Jon Bradley, Vice-President, Sales — EMEA
|
|||||
Business Performance Measures
|
Incentive Targets (US$)
|
Results (US$)
|
|||
Contribution Margin Bonus (1)
|
73,382
|
68,245
|
|||
Bonus on Billings (2)
|
20,013
|
19,188
|
|||
Bonus on Strategic Sales Objectives (3)
|
30,020
|
26,210
|
|||
Long-Term Expansion Bonus (4)
|
10,007
|
9,376
|
|||
Total
|
133,422
|
123,019
|
|||
(1)
|
The amount of bonus for the attainment of the quarterly contribution margin targets for the territory of the EMEA is based on the percentage of achievement from above 35% to 100% of the quarterly contribution margin targets defined at the beginning of the financial year. An accelerated amount of bonus based on the percentage of attainment of the quarterly contribution margin targets above 100% is also payable.
|
(2)
|
The amount of bonus for the attainment of the billings targets for the territory of the EMEA is based on the percentage of achievement from above 50% to 100% of the quarterly billings targets defined at the beginning of the financial year. An additional amount of bonus based on the percentage of attainment from above 100% to 125% of the quarterly billings targets is also payable. Upon percentage of achievement above 125% of the quarterly billings targets, such corresponding exceeding portion of percentage achievement is added to the next quarter for the calculation of the amount of bonus and capped to 150% of achievement.
|
(3)
|
The amount of bonus for the attainment of the specific product lines bookings targets for the territory of the EMEA is based on the percentage of achievement from above 50% to 100% of the annual bookings targets of the specific product lines defined at the beginning of the financial year. An accelerated amount of bonus based on the percentage of attainment of the specific product lines bookings targets for the territory of the EMEA above 100% is also payable.
|
(4)
|
The amount of bonus for the contribution margin growth targets for the territory of the EMEA in fiscal year 2017 is based on the percentage of such growth from above 5% to 15%.
|
Dana Yearian, Vice-President, Sales — Americas
|
|||||
Business Performance Measures
|
Incentive Targets (US$)
|
Results (US$)
|
|||
Contribution Margin Bonus (1)
|
124,979
|
113,142
|
|||
Bonus on Billings (2)
|
31,245
|
30,628
|
|||
Bonus on Strategic Sales Objectives (3)
|
33,849
|
19,470
|
|||
Long-Term Expansion Bonus (4)
|
18,226
|
18,226
|
|||
Total
|
208,299
|
181,465
|
|||
(1)
|
The amount of bonus for the attainment of the quarterly contribution margin targets for the territory of the Americas is based on the percentage of achievement from above 35% to 100% of the quarterly contribution margin targets defined at the beginning of the financial year. An accelerated amount of bonus based on the percentage of attainment of the quarterly contribution margin targets above 100% is also payable.
|
(2)
|
The amount of bonus for the attainment of the billings targets for the territory of the Americas is based on the percentage of achievement from above 50% to 100% of the quarterly billings targets defined at the beginning of the financial year. An additional amount of bonus based on the percentage of attainment from above 100% to 125% of the quarterly billings targets is also payable. Upon percentage of achievement above 125% of the quarterly billings targets, such corresponding exceeding portion of percentage achievement is added to the next quarter for the calculation of the amount of bonus and capped to 150% of achievement.
|
(3)
|
The amount of bonus for the attainment of the specific product lines bookings targets for the territory of the Americas is based on the percentage of achievement from above 50% to 100% of the annual bookings targets of the specific product lines defined at the beginning of the financial year. An accelerated amount of bonus based on the percentage of attainment of the specific product lines bookings targets for the territory of the Americas above 100% is also payable.
|
(4)
|
The amount of bonus for the contribution margin growth targets for the territory of the Americas in fiscal year 2017 is based on the percentage of such growth from above 5% to 15%.
|
Name & Position
|
Grant Levels (1) (% of Previous Year Base Salary)
|
||
Philippe Morin, COO
|
50.0%
|
(2)
|
|
Pierre Plamondon, Vice-President, Finance and CFO
|
42.5%
|
||
Jon Bradley Vice-President, Sales ─ EMEA
|
42.5%
|
||
Dana Yearian, Vice-President, Sales ─ Americas
|
42.5%
|
||
(1)
|
Actual grant value may differ from the grant level guidelines as the stock price may vary between the time of the grant and its approval.
|
(2)
|
Current year base salary since he did not have a base salary for the previous year.
|
Financial
Year Ended |
Grant Date
|
RSUs
Granted (#) |
Fair Value
at the Time of Grant (US$/RSU) |
Vesting Schedule
|
|
August 31, 2016
|
October 15, 2015
|
36,900
|
3.23
|
50% on each of the third and fourth anniversary dates of the grant.
|
|
November 9, 2015
|
109,890
|
3.43
|
|||
January 13, 2016
|
151,400
|
3.00
|
|||
July 7, 2016
|
2,500
|
3.30
|
|||
August 15, 2016
|
10,000
|
3.33
|
|||
October 15, 2015
|
206,373
|
3.23
|
100% on the fifth anniversary date of the grant subject to early vesting of up to 1/3 on the third anniversary date of the grant and up to 50% of the remaining units on the fourth anniversary date of the grant if performance objectives namely related to long-term growth of revenue and profitability, as determined by the Board of Directors of the Corporation, are fully attained.
|
||
November 9, 2015
|
54,945
|
3.43
|
|||
Total
|
572,008
|
||||
August 31, 2015
|
October 16, 2014
|
29,150
|
3.71
|
50% on each of the third and fourth anniversary dates of the grant.
|
|
January 14, 2015
|
163,400
|
3.55
|
|||
March 31, 2015
|
5,000
|
3.78
|
|||
July 2, 2015
|
12,299
|
3.27
|
|||
October 16, 2014
|
197,726
|
3.71
|
100% on the fifth anniversary date of the grant subject to early vesting of up to 1/3 on the third anniversary date of the grant and up to 50% of the remaining units on the fourth anniversary date of the grant if performance objectives namely related to long-term growth of revenue and profitability, as determined by the Board of Directors of the Corporation, are fully attained.
|
||
July 2, 2015
|
1,946
|
3.27
|
|||
Total
|
409,521
|
||||
August 31, 2014
|
October 16, 2013
|
36,950
|
5.28
|
50% on each of the third and fourth anniversary dates of the grant.
|
|
January 15, 2014
|
132,000
|
4.36
|
|||
July 3, 2014
|
29,502
|
4.77
|
|||
October 16, 2013
|
138,233
|
5.28
|
100% on the fifth anniversary date of the grant subject to early vesting of up to 1/3 on the third anniversary date of the grant and up to 50% of the remaining units on the fourth anniversary date of the grant if performance objectives namely related to long-term growth of revenue and profitability, as determined by the Board of Directors of the Corporation, are fully attained.
|
||
Total
|
336,685
|
||||
August 31, 2013
|
October 16, 2012
|
30,006
|
5.06
|
50% on each of the third and fourth anniversary dates of the grant.
|
|
January 16, 2013
|
145,750
|
5.61
|
|||
October 16, 2012
|
140,404
|
5.06
|
100% on the fifth anniversary date of the grant subject to early vesting of up to 1/3 on the third anniversary date of the grant and up to 50% of the remaining units on the fourth anniversary date of the grant if performance objectives namely related to long-term growth of revenue and profitability, as determined by the Board of Directors of the Corporation, are fully attained.
|
||
Total
|
316,160
|
||||
August 31, 2012
|
October 18, 2011
|
23,000
|
5.43
|
50% on each of the third and fourth anniversary dates of the grant.
|
|
January 17, 2012
|
8,321
|
6.61
|
|||
January 18, 2012
|
122,000
|
6.47
|
|||
January 23, 2012
|
7,576
|
6.55
|
|||
April 3, 2012
|
2,571
|
7.06
|
|||
October 18, 2011
|
163,651
|
5.43
|
100% on the fifth anniversary date of the grant subject to early vesting of up to 1/3 on the third anniversary date of the grant and up to 50% of the remaining units on the fourth anniversary date of the grant if performance objectives namely related to long-term growth of revenue and profitability, as determined by the Board of Directors of the Corporation, are fully attained.
|
||
January 23, 2012
|
6,330
|
6.55
|
|||
April 3, 2012
|
1,429
|
7.06
|
|||
Total
|
334,878
|
Name
|
RSUs
Granted (#) |
Percentage of Total
RSUs Granted to Employees in Financial Year (%) (1) |
Fair Value
at the Time of Grant (US$/RSU) (2) |
Grant Date
|
Vesting Schedule (3)
|
Philippe Morin
|
109,890
|
19.21%
|
3.43
|
November 9, 2015
|
50% on each of the third and fourth anniversary dates of the grant.
|
54,945
|
9.61%
|
3.43
|
November 9, 2015
|
100% on the fifth anniversary date of the grant subject to early vesting up to 1/3 on the third anniversary date of the grant and up to 50% of the remaining units on the fourth anniversary date of the grant if performance objectives namely related to long-term growth of revenue and profitability, as determined by the Board of Directors of the Corporation are fully attained. (4)
|
|
Pierre Plamondon
|
29,046
|
5.08%
|
3.23
|
October 15, 2015
|
100% on the fifth anniversary date of the grant subject to early vesting up to 1/3 on the third anniversary date of the grant and up to 50% of the remaining units on the fourth anniversary date of the grant if performance objectives namely related to long-term growth of revenue and profitability, as determined by the Board of Directors of the Corporation are fully attained. (4)
|
Jon Bradley
|
26,575
|
4.65%
|
3.23
|
October 15, 2015
|
100% on the fifth anniversary date of the grant subject to early vesting up to 1/3 on the third anniversary date of the grant and up to 50% of the remaining units on the fourth anniversary date of the grant if performance objectives namely related to long-term growth of revenue and profitability, as determined by the Board of Directors of the Corporation are fully attained. (4)
|
Dana Yearian
|
30,058
|
5.25%
|
3.23
|
October 15, 2015
|
100% on the fifth anniversary date of the grant subject to early vesting up to 1/3 on the third anniversary date of the grant and up to 50% of the remaining units on the fourth anniversary date of the grant if performance objectives namely related to long-term growth of revenue and profitability, as determined by the Board of Directors of the Corporation are fully attained. (4)
|
(1)
|
Such percentage does not include any cancelled RSUs.
|
(2)
|
The fair value at the time of grant of a RSU is equal to the market value of Subordinate Voting Shares at the time RSUs are granted. The grant date market value is equal to the highest of the closing prices of the Subordinate Voting Shares on the Toronto Stock Exchange and the NASDAQ National Market on the last trading day preceding the grant date, using the noon buying rate of the Bank of Canada on the grant date to convert either the NASDAQ National Market closing price to Canadian dollars or the Toronto Stock Exchange closing price to United States dollars as required.
|
(3)
|
All RSUs first vesting cannot be earlier than the third anniversary date of their grant.
|
(4)
|
Those RSUs granted in the financial year ended August 31, 2016 vest on the fifth anniversary date of the grant but are subject to early vesting on the third and fourth anniversary date of the grant on the attainment of performance objectives, as determined by the Board of Directors of the Corporation. Accordingly, subject to the attainment of performance objectives, the first early vesting is up to 1/3 of the units on the third anniversary date of the grant and the second early vesting is up to 50% of the remaining units on the fourth anniversary date of the grant. The early vesting shall be subject to the attainment of performance objectives. Such performance objectives are based on the attainment of a sales growth metric combined with profitability metric. The sales growth metric is determined by the Compound Annual Growth Rate of sales of the Corporation for the period described below (SALES CAGR). The profitability metric is determined as the Cumulative Corporation's IFRS net earnings before interest, income taxes, depreciation of property, plant and equipment, amortization of intangible assets, foreign exchange gain or loss, change in fair value of cash contingent consideration, and extraordinary gain or loss over the Cumulative Sales for the same period (LTIP EBITDA). Accordingly, the first early vesting performance objectives will be attained, calculated on a pro-rated basis as follows: i) 100% for a SALES CAGR of 20% or more and 0% for a SALES CAGR of 5% or less for the three-year period ending on August 31, 2018; cumulated with ii) 100% for a LTIP EBITDA of 15% and 0% for a LTIP EBITDA of 7.5% or less for the three-year period ending on August 31, 2018. The second early vesting performance objectives will be attained on the same premises as described above but for the four-year period ending on August 31, 2019.
|
Number of
RSUs (#) |
% of Issued and
Outstanding RSUs |
Weighted Average Fair Value at
the Time of Grant ($US/RSU) |
||||
President and CEO (one (1) individual)
|
53,261
|
3.43%
|
5.43
|
|||
Board of Directors (five (5) individuals)
|
–
|
–
|
–
|
|||
Management and Corporate Officers (twelve (12) individuals)
|
893,467
|
57.59%
|
4.11
|
DSUs
Granted (#) |
Weighted Average Fair Value
at the Time of Grant (US$/DSU) |
Total of the Fair Value
at the Time of Grant (US$) |
Vesting
|
44,970
|
3.33
|
149,750
|
At the time director ceases to be a member of the Board of
Directors of the Corporation
|
Number of
DSUs (#) |
% of Issued and
Outstanding DSUs |
Total of the Fair Value at
the Time of Grant (US$) |
Weighted Average Fair Value
at the Time of Grant (US$/DSU) |
|
Board of Directors (five (5) individuals)
|
159,127
|
100%
|
636,508
|
4.00
|
Long-Term Incentive Plan (LTIP) - RSUs
|
|||
Date of Grant
|
Vesting Date
|
% of Early Vesting Achievement (1)
|
|
October 16, 2012
|
October 17, 2016
|
0%
|
|
October 16, 2013
|
October 17, 2016
|
0%
|
|
(1)
|
The vesting schedules are provided in the table under the heading "Long-Term Incentive Plan".
|
Compensation Elements
|
2016
|
2015
|
2014
|
Three-Year Total
|
||||
Cash
|
||||||||
Base Salary
|
CA$700,000
|
CA$615,332
|
CA$557,767
|
CA$1,873,099
|
||||
Short-Term Incentive
|
CA$331,115
|
CA$101,022
|
CA$214,300
|
CA$646,437
|
||||
Equity
|
||||||||
Long-Term Incentive
|
–
|
–
|
–
|
–
|
||||
Total Direct Compensation
|
CA$1,031,115 | CA$716,354 | CA$772,067 | CA$2,519,536 | ||||
Pension Value
|
–
|
–
|
–
|
–
|
||||
All Other Compensation
|
–
|
–
|
–
|
–
|
||||
Total Compensation
|
CA$1,031,115
|
CA$716,354
|
CA$772,067
|
CA$2,519,536
|
||||
Annual Average
|
–
|
–
|
–
|
CA$839,845
|
||||
Total Market Capitalization (CA$ millions) as at August 31 (1)
|
231.9
|
217.6
|
286.6
|
245.4
|
||||
Total Cost as a % of Market Capitalization
|
0.44%
|
0.33%
|
0.27%
|
0.34%
|
(1)
|
In fiscal year 2015, the Corporation redeemed 6,521,739 subordinate voting shares under the Substantial Issuer Bid.
|
Name and
Principal Position |
Financial
Year |
Salary (1) (2)
($) |
Share-Based
Awards (2) (3) ($) |
Option-
Based Awards ($) |
Non-Equity Incentive
Plan Compensation ($) |
Pension
Value ($) |
All Other
Compensation ($) (2) (5) |
Total
Compensation ($) |
||||||||
Annual
Incentive Plans (2) (4) |
Long-Term
Incentive Plan |
|||||||||||||||
Germain Lamonde,
President and CEO |
2016
|
527,188 (US)
700,000 (CA) |
–
– |
(US)
(CA) |
–
|
249,371
331,115 |
(US)
(CA) |
–
|
–
|
–
|
776,559
1,031,115 |
(US)
(CA) |
||||
2015
|
508,833 (US)
615,332 (CA) |
–
– |
(US)
(CA) |
–
|
83,537
101,022 |
(US)
(CA) |
–
|
–
|
–
|
592,370
716,354 |
(US)
(CA) |
|||||
2014
|
517,313 (US)
557,767 (CA) |
–
– |
(US)
(CA) |
–
|
198,757
214,300 |
(US)
(CA) |
–
|
–
|
–
|
716,070
772,067 |
(US)
(CA) |
|||||
Philippe Morin,
COO |
2016
|
296,905 (US) (6)
394,231 (CA) |
564,844
749,999 |
(US)
(CA) |
–
|
107,388
142,589 |
(US)
(CA) |
–
|
–
|
6,879
9,135 |
(US)
(CA) |
976,016
1,295,954 |
(US)
(CA) |
|||
Pierre Plamondon,
Vice-President, Finance and CFO |
2016
|
221,502 (US)
294,110 (CA) |
91,220
121,122 |
(US)
(CA) |
–
|
82,291
109,266 |
(US)
(CA) |
–
|
–
|
9,064
12,035 |
(US)
(CA) |
404,077
536,533 |
(US)
(CA) |
|||
2015
|
235,665 (US)
284,990 (CA) |
95,847
115,907 |
(US)
(CA) |
–
|
31,095
37,603 |
(US)
(CA) |
–
|
–
|
12,212
14,768 |
(US)
(CA) |
374,819
453,268 |
(US)
(CA) |
||||
2014
|
252,938 (US)
272,718 (CA) |
100,465
108,321 |
(US)
(CA) |
–
|
69,448
74,879 |
(US)
(CA) |
–
|
–
|
11,667
12,579 |
(US)
(CA) |
434,518
468,497 |
(US)
(CA) |
||||
Jon Bradley,
Vice-President, Sales — EMEA |
2016
|
179,973 (US)
238,968 (CA) 124,739 (£) |
85,837
113,975 59,494 |
(US)
(CA) (£) |
–
|
123,019
163,344 85,264 |
(US)
(CA) (£) |
–
|
–
|
–
|
388,829
516,287 269,497 |
(US)
(CA) (£) |
||||
2015
|
193,664 (US)
234,198 (CA) 124,739 (£) |
83,579
101,072 53,833 |
(US)
(CA) (£) |
–
|
78,315
94,706 50,442 |
(US)
(CA) (£) |
–
|
–
|
–
|
355,558
429,976 229,014 |
(US)
(CA) (£) |
|||||
2014
|
200,594 (US)
216,280 (CA) 121,459 (£) |
71,402
76,986 45,740 |
(US)
(CA) (£) |
–
|
116,563
125,678 70,579 |
(US)
(CA) (£) |
–
|
–
|
–
|
388,559
418,944 237,778 |
(US)
(CA) (£) |
|||||
Dana Yearian,
Vice-President, Sales — Americas |
2016
|
233,465 (US)
309,995 (CA) |
97,087
128,913 |
(US)
(CA) |
–
|
181,465
240,949 |
(US)
(CA) |
–
|
–
|
7,049
9,360 |
(US)
(CA) |
519,066
689,217 |
(US)
(CA) |
|||
2015
|
228,439 (US)
276,251 (CA) |
95,369
115,330 |
(US)
(CA) |
–
|
156,372
189,100 |
(US)
(CA) |
–
|
–
|
7,049
8,525 |
(US)
(CA) |
487,229
589,206 |
(US)
(CA) |
||||
2014
|
224,400 (US)
241,948 (CA) |
93,329
100,627 |
(US)
(CA) |
–
|
140,579
151,573 |
(US)
(CA) |
–
|
–
|
7,049
7,601 |
(US)
(CA) |
465,357
501,749 |
(US)
(CA) |
||||
(1)
|
Base salary earned in the financial year, regardless when paid.
|
(2)
|
The compensation information for Canadian residents has been converted from Canadian dollars to US dollars based upon an average foreign exchange rate of CA$1.3278 = US$1.00 for the financial year ended August 31, 2016, CA$1.2093 = US$1.00 for the financial year ended August 31, 2015 and CA$1.0782 = US$1.00 for the financial year ended August 31, 2014. The compensation information for UK resident has been converted from British Pounds to US dollars based upon an average foreign exchange rate of £0.6931 = US$1.00 for the financial year ended August 31, 2016, £0.6441 = US$1.00 for the financial year ended August 31, 2015 and £0.6055 = US$1.00 for the financial year ended August 31, 2014 and the conversion from US dollars to Canadian dollars is made as described above.
|
(3)
|
Indicates the dollar amount based on the grant date fair value of the RSUs awarded under the LTIP for the financial year. The grant date fair value is equal to the highest of the closing prices of the Subordinate Voting Shares on the Toronto Stock Exchange and the NASDAQ National Market on the last trading day preceding the grant date, using the noon buying rate of the Bank of Canada on the grant date to convert either the NASDAQ National Market closing price to Canadian dollars or the Toronto Stock Exchange closing price to United States dollars. Grants of RSUs to NEOs are detailed under section "Compensation Discussion and Analysis – Long-Term Incentive Plan".
|
(4)
|
Indicates the total bonus earned during the financial year whether paid during the financial year or payable on a later date:
|
Name
|
Paid during the
Financial Year Ended August 31, 2016 (i) ($) |
Paid in the First Quarter
of the Financial Year Ending on August 31, 2017 (i) ($) |
Total Bonus Earned during
the Financial Year Ended August 31, 2016 (i) ($) |
|||||
Germain Lamonde
|
‒
‒ |
(US)
(CA) |
249,371
331,115 |
(US)
(CA) |
249,371
331,115 |
(US)
(CA) |
||
Philippe Morin
|
‒
‒ |
(US)
(CA) |
107,388
142,589 |
(US)
(CA) |
107,388
142,589 |
(US)
(CA) |
||
Pierre Plamondon
|
‒
‒ |
(US)
(CA) |
82,291
109,266 |
(US)
(CA) |
82,291
109,266 |
(US)
(CA) |
||
Jon Bradley
|
63,591
84,436 44,075 |
(US)
(CA) (£) |
59,428
78,908 41,189 |
(US)
(CA) (£) |
123,019
163,344 85,264 |
(US)
(CA) (£) |
||
Dana Yearian
|
98,141
130,312 |
(US)
(CA) |
83,324
110,637 |
(US)
(CA) |
181,465
240,949 |
(US)
(CA) |
||
(5)
|
Indicates the amount contributed by the Corporation during the financial year to the DPSP as detailed under section "Compensation Discussion and Analysis – Deferred Profit-Sharing Plan", the 401K plan as detailed under section "Compensation Discussion and Analysis – 401K plan", as applicable, for the benefit of the NEOs. Mr. Lamonde is not eligible to participate in the DPSP and Mr. Bradley did not participate.
|
(6)
|
This amount represents the salary paid to Mr. Philippe Morin from November 9, 2015 to August 31, 2016 which is based on an annual salary of US$376,563 (CA$500,000) for the financial year ended August 31, 2016.
|
Name
|
Outstanding Option-Based Awards (Options)
|
Outstanding Share-Based Awards (RSUs)
|
||||||||
Number of
Securities Underlying Unexercised Options (#) |
Option
Exercise Price |
Option
Expiration Date |
Value of
Unexercised "in-the-money" Options |
Number of
Shares or Units of Shares that Have Not Vested (#) |
Market or
Payout Value of Share-Based Awards that Have Not Vested (US$) (1) |
Market or
Payout Value of Vested Share- Based Awards Not Paid Out or Distributed (US$) |
||||
Germain Lamonde
|
–
|
–
|
–
|
–
|
53,261
|
175,761
|
–
|
|||
Philippe Morin
|
–
|
–
|
–
|
–
|
164,835
|
543,956
|
–
|
|||
Pierre Plamondon
|
–
|
–
|
–
|
–
|
113,679
|
375,141
|
–
|
|||
Jon Bradley
|
–
|
–
|
–
|
–
|
88,547
|
292,205
|
–
|
|||
Dana Yearian
|
–
|
–
|
–
|
–
|
106,756
|
352,295
|
–
|
|||
(1)
|
The value of unvested RSUs at the financial year-end is the market value of the Subordinate Voting Shares on August 31, 2016, which was US$3.30 (CA$4.33). The market value of the Subordinate Voting Shares was calculated by using the highest of the closing prices of the Subordinate Voting Shares on the Toronto Stock Exchange and on the NASDAQ National Market on August 31, 2016 using the noon buying rate of the Bank of Canada to convert either the NASDAQ National Market closing price to Canadian dollars or the Toronto Stock Exchange closing price to United States dollars as required. The actual gains on vesting will depend on the value of the Subordinate Voting Shares on the date of vesting. There can be no assurance that these values will be realized.
|
Name
|
Share-Based Awards – Value
Vested during the Year (US$) (1) |
Non-Equity Incentive Plan Compensation –
Value Earned during the Year (US$) (2) |
|||
Germain Lamonde
|
132,457
|
249,371
|
|||
Philippe Morin
|
‒
|
107,388
|
|||
Pierre Plamondon
|
64,581
|
82,291
|
|||
Jon Bradley
|
51,214
|
123,019
|
|||
Dana Yearian
|
61,406
|
181,465
|
|||
(1)
|
The aggregate dollar value realized is equivalent to the market value of the Subordinate Voting Shares underlying the RSUs at vesting. This value, as the case may be, has been converted from Canadian dollars to US dollars based upon the noon buying rate of the Bank of Canada on the day of vesting.
|
(2)
|
Includes total non-equity incentive plan compensation earned by each NEO in respect to the financial year ended on August 31, 2016 (as indicated under the "Summary Compensation Table").
|
Named Executive Officer
|
Termination Payment Event
|
||||||
Without Cause ($) (1) (2)
|
Change of Control ($) (2) (3) (4)
|
Voluntary ($)
|
|||||
Germain Lamonde
|
1,748,061
2,292,850 |
(US) (5)
(CA) |
1,748,061
2,292,850 |
(US)
(CA) |
175,761
230,620 |
(US) (6)
(CA) |
|
Philippe Morin
|
496,315
651,026 |
(US)
(CA) |
925,170
1,213,736 |
(US)
(CA) |
–
|
||
Pierre Plamondon
|
419,202
549,926 |
(US)
(CA) |
836,459
1,097,294 |
(US)
(CA) |
–
|
||
Jon Bradley
|
306,092
401,544 233,035 |
(US)
(CA) (£) |
705,963
926,094 537,467 |
(US)
(CA) (£) |
–
|
||
Dana Yearian
|
411,503
539,821 |
(US)
(CA) |
974,690
1,278,586 |
(US)
(CA) |
–
|
||
(1)
|
The aggregate amount disclosed includes an evaluation of the amount that the NEO would have been entitled to should a termination of employment without cause have occurred on August 31, 2016 and includes, as the case may be for each NEO, the base salary that would have been received and total value of RSUs and options that would have vested (with the exception of Mr. Lamonde's evaluation which is described in note 6 below and includes: the base salary, STIP compensation, and total value of RSUs and options that would have vested). The amount for base salary compensation is calculated according to those amounts provided under the section entitled "Summary Compensation Table" included in this Annual Report. The amount for the total value attached to the vesting of RSUs and options determined pursuant to the LTIP as described in the section entitled "Long-Term Incentive Compensation – Long-Term Incentive Plan" for termination without cause.
|
(2)
|
The aggregate amount for Canadian residents has been converted from Canadian dollars to US dollars based upon a foreign exchange rate of CA$1.3116 = US$1.00 as of August 31, 2016. The aggregate amount for UK resident has been converted from British Pounds to US dollars based upon a foreign exchange rate of £0.7613 = US$1.00 as of August 31, 2016.
|
(3)
|
"Change of Control" is defined as a merger or an acquisition by a third party of substantially all of the Corporation's assets or of the majority of its share capital.
|
(4)
|
The aggregate amount disclosed includes, as the case may be for each NEO, an evaluation of the amount that the NEO would have been entitled to should a termination of employment for Change of Control have occurred on August 31, 2016 and includes, as the case may be, namely, the base salary, STIP or SIP compensation and total value of RSUs and options that would have vested. The amount for base salary and STIP or SIP compensation are calculated according to those amounts provided under the section entitled "Summary Compensation Table" included in this Annual Report, the total value attached to the vesting of RSUs and options is calculated according to those amounts provided in the columns named "Value of unexercised "in-the-money" options" and "Market or payout value of share-based awards that have not vested" of the table included under the heading entitled "Outstanding share-based awards and option-based awards".
|
(5)
|
The aggregate amount disclosed includes an evaluation of the amount that Mr. Lamonde would have been entitled to should a termination of employment without cause have occurred on August 31, 2016 and includes: the base salary, STIP compensation, and total value of RSUs and options that would have vested. The amount for base salary and STIP compensation are calculated according to those amounts provided under the section entitled "Summary Compensation Table" included in this Annual Report; the total value attached to the vesting of RSUs and options are calculated according to those amounts provided in the columns named "Value of unexercised "in-the-money" options" and "Market or payout value of share-based awards that have not vested" of the table included under the heading entitled – "Outstanding share-based awards and option-based awards".
|
(6)
|
The aggregate amount disclosed includes an evaluation of the amount that Mr. Lamonde would have been entitled to should a voluntary termination of employment have occurred on August 31, 2016 and includes: the total value of RSUs and options that would have vested. The amount for the total value attached to the vesting of RSUs and options are calculated according to those amounts provided in the columns named "Value of unexercised "in-the-money" options" and "Market or payout value of share-based awards that have not vested" of the table included under the heading entitled "Outstanding share-based awards and option-based awards".
|
Annual Retainer for Directors (1)
|
CA$57,000
|
(2)
|
US$42,928
|
(3)
|
|
Annual Retainer for Lead Director
|
CA$8,000
|
US$6,025
|
(3)
|
||
Annual Retainer for Audit Committee Chairman
|
CA$8,000
|
US$6,025
|
(3)
|
||
Annual Retainer for Audit Committee Members
|
CA$4,000
|
US$3,013
|
(3)
|
||
Annual Retainer for Human Resources Committee Chairman
|
CA$6,000
|
US$4,519
|
(3)
|
||
Annual Retainer for Human Resources Committee Members
|
CA$3,000
|
US$2,259
|
(3)
|
||
(1)
|
All the Directors elected to receive 50% of their Annual Retainer for Directors in form of DSUs except Mr. Randy E. Tornes who elected to receive 100% of his Annual Retainer in form of DSUs.
|
(2)
|
The Annual Retainer for Mr. Pierre-Paul Allard and Mr. Randy E. Tornes is US$57,000 (CA$75,685).
|
(3)
|
The compensation information has been converted from Canadian dollars to US dollars based upon an average foreign exchange rate of CA$1.3278 = US$1.00 for the financial year ended August 31, 2016.
|
Name
|
Fees
Earned (1) ($) |
Share-Based
Awards ($) |
Option-
Based Awards ($) |
Non-Equity
Incentive Plan Compensation ($) |
Pension
Value ($) |
All Other
Compensation ($) |
Total
($) |
|||
Pierre-Paul Allard
|
62,272
82,684 |
(US)
(CA) |
–
|
–
|
–
|
–
|
–
|
62,272
82,684 |
(US)
(CA) |
|
François Côté
|
54,366
72,187 |
(US)
(CA) |
–
|
–
|
–
|
–
|
–
|
54,366
72,187 |
(US)
(CA) |
|
Darryl Edwards
|
50,318
66,813 |
(US)
(CA) |
–
|
–
|
–
|
–
|
–
|
50,318
66,813 |
(US)
(CA) |
|
Claude Séguin
|
51,212
68,000 |
(US)
(CA) |
–
|
–
|
–
|
–
|
–
|
51,212
68,000 |
(US)
(CA) |
|
Randy E. Tornes
|
62,272
82,685 |
(US)
(CA) |
–
|
–
|
–
|
–
|
–
|
62,272
82,685 |
(US)
(CA) |
|
(1)
|
The compensation information has been converted from Canadian dollars to US dollars based upon an average foreign exchange rate of CA$1.3278 = US$1.00 for the financial year ended August 31, 2016 except for compensation amounts paid to Mr. Pierre-Paul Allard and Mr. Randy E. Tornes which were paid in US dollars for the portion of their annual retainer for Directors. The fees are always payable in cash, but executives are provided the opportunity to elect to exchange all or a portion of their Annual Retainer for Directors into DSUs. The following table identifies the portion of the fees earned by the directors that were paid in DSUs and the portion that were paid in cash.
|
Name
|
Fees Earned
|
|||||||
DSUs ($) (i)
|
Cash ($)
|
Total ($)
|
||||||
Pierre-Paul Allard (ii)
|
28,500
37,842 |
(US)
(CA) |
33,772
44,842 |
(US)
(CA) |
62,272
82,684 |
(US)
(CA) |
||
François Côté (ii)
|
21,464
28,500 |
(US)
(CA) |
32,902
43,687 |
(US)
(CA) |
54,366
72,187 |
(US)
(CA) |
||
Darryl Edwards (ii)
|
21,464
28,500 |
(US)
(CA) |
28,854
38,313 |
(US)
(CA) |
50,318
66,813 |
(US)
(CA) |
||
Claude Séguin (ii)
|
21,464
28,500 |
(US)
(CA) |
29,748
39,500 |
(US)
(CA) |
51,212
68,000 |
(US)
(CA) |
||
Randy E. Tornes (iii)
|
57,000
75,685 |
(US)
(CA) |
5,272
7,000 |
(US)
(CA) |
62,272
82,685 |
(US)
(CA) |
||
(i)
|
The estimated value at the time of grant of a DSU is determined based on the highest of the closing prices of the Subordinate Voting Shares on the Toronto Stock Exchange and the NASDAQ National Market on the last trading day preceding the grant date, using the noon buying rate of the Bank of Canada on the grant date to convert either the NASDAQ National Market closing price to Canadian dollars or the Toronto Stock Exchange closing price to United States dollars, as required. The value at vesting of a DSU is equivalent to the market value of a Subordinate Voting Share when a DSU is converted to such Subordinate Voting Share.
|
(ii)
|
Elected to receive 50% of his Annual Retainer for Directors in form of DSUs.
|
(iii)
|
Elected to receive 100% of his Annual Retainer for Directors in form of DSUs.
|
Name
|
Outstanding Share-Based Awards (DSUs)
|
|||||
Number of Shares or Units of
Shares that Have Not Vested (#) |
Market or Payout Value of
Share-Based Awards that Have Not Vested (US$) (1) |
Market or Payout Value of
Vested Share-Based Awards Not Paid Out or Distributed (US$) |
||||
Pierre-Paul Allard
|
48,883
|
161,314
|
‒
|
|||
François Côté
|
10,809
|
35,670
|
–
|
|||
Darryl Edwards
|
28,217
|
93,116
|
–
|
|||
Claude Séguin
|
21,755
|
71,792
|
–
|
|||
Randy E. Tornes
|
49,463
|
163,228
|
–
|
|||
(1)
|
The value of unvested DSUs at the financial year-end is the market value of the Subordinate Voting Shares on August 31, 2016, which was US$3.30 (CA$4.33). The market value of the Subordinate Voting Shares was calculated by using the highest of the closing prices of the Subordinate Voting Shares on the Toronto Stock Exchange and on the NASDAQ National Market on August 31, 2016 using the noon buying rate of the Bank of Canada to convert either the NASDAQ National Market closing price to Canadian dollars or the Toronto Stock Exchange closing price to United States dollars as required. The actual gains on vesting will depend on the value of the Subordinate Voting Shares on the date of vesting. There can be no assurance that these values will be realized.
|
Name
|
Number of DSUs Converted
|
Aggregate Value Realized (US$) (1)
|
|
Guy Marier (2)
|
653
|
1,955
|
|
(1)
|
The aggregate value realized is equivalent to the market value of the securities underlying the DSUs at conversion.
|
(2)
|
Mr. Marier ceased to be a member of the Board of Directors as of January 7, 2015.
|
Plan Category
|
Number of Securities to Be
Issued upon Exercise of Outstanding Options, RSUs and DSUs (#) (a) |
Weighted-Average Exercise
Price of Outstanding Options, RSUs and DSUs (US$) (b) |
Number of Securities Remaining
Available for Future Issuance under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) (#) (c) |
|||
LTIP – RSUs
|
1,551,555
|
n/a (1)
|
867,716
|
|||
LTIP – Options
|
–
|
–
|
||||
Deferred Share Unit Plan – DSUs
|
159,127
|
n/a (1)
|
||||
(1)
|
The value of RSUs and DSUs will be equal to the market value of the Subordinate Voting Shares of the Corporation on the date of vesting.
|
August 31,
|
||||||||||||||||||||||||
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
|||||||||||||||||||
EXFO Subordinate Voting Shares (CA$)
|
$
|
100
|
$
|
70
|
$
|
70
|
$
|
70
|
$
|
59
|
$
|
63
|
||||||||||||
S&P/TSX Composite Index (CA$)
|
$
|
100
|
$
|
94
|
$
|
100
|
$
|
123
|
$
|
109
|
$
|
115
|
||||||||||||
NEOs' total compensation (in millions of CA$)
|
$
|
2.7
|
$
|
2.5
|
$
|
2.3
|
$
|
2.6
|
$
|
2.6
|
$
|
4.1
|
·
|
The Corporation's share performance decreased from the financial year that began on September 1, 2011 to the financial year ended August 31, 2012. Total compensation received by the NEOs during this period was aligned with the decrease in the Corporation's share price.
|
·
|
Despite the relative stability of the Corporation's share price as at August 31, 2013 compared to the previous financial year, total compensation to the NEOs decreased. This decrease in NEOs compensation reflected financial results below expectations for financial 2013 and consequently was aligned with shareholders' interests.
|
·
|
The Corporation's share price remained relatively flat as at August 31, 2014 compared to the previous financial year, but total NEO compensation increased for that year. This rise in NEO compensation can be explained mainly by the progressive adjustment of the CEO's base salary, as he no longer received equity-based compensation, as well as adjustments to align executive compensation with the Target Compensation Positioning offered within a reference market of comparable companies similar in size to the Corporation. This was deemed necessary to maintain a competitive position within the marketplace and retain key executives.
|
·
|
The Corporation's share price decreased as at August 31, 2015 compared to the previous financial year, while total NEO compensation as expressed in Canadian dollars remained flat for the same period. It should be noted, however, three out of five NEOs were remunerated in currencies other than the Canadian dollar. On a constant currency basis, total NEO compensation would have decreased by about CA$100,000 year-over-year. As a result, total compensation received by the NEOs for this period was aligned with share price performance.
|
·
|
The Corporation's share performance increased from September 1, 2015 to August 31, 2016. Total compensation received by the NEOs during this period also increased but at a higher rate than the Corporation's share price. It should be noted that the Corporation hired an executive to the newly created position of Chief Operating Officer in the early part of the financial year, which also contributed to the increase in total compensation received by the NEOs during this period.
|
(a)
|
one (1) copy of the Annual Report on Form 20-F of the Corporation filed with the SEC in the United States pursuant to the Securities Exchange Act of 1934, and with securities commissions or similar authorities;
|
(b)
|
one (1) copy of the consolidated financial statements and the Auditors report thereon as well as the Management's discussion and analysis of financial condition and results of operations of the Corporation for its most recently completed financial year, included in the Annual Report on Form 20-F of the Corporation and one (1) copy of any interim consolidated financial statements of the Corporation subsequent to the consolidated financial statements for its most recently completed financial year;
|
(c)
|
one (1) copy of this Management Proxy Circular.
|
CSA Guidelines
|
EXFO's Corporate Governance Practices
|
|||
1.
|
Board of Directors
|
|||
(a)
|
Disclose the identity of directors who are independent.
|
The following directors are independent:
Mr. Pierre-Paul Allard
Mr. François Côté Mr. Darryl Edwards Mr. Claude Séguin Mr. Randy E. Tornes |
||
(b)
|
Disclose the identity of directors who are not independent, and describe the basis for that determination.
|
Mr. Germain Lamonde – non-independent – is President and Chief Executive Officer of the Corporation and the majority shareholder of the Corporation as he has the ability to exercise a majority of the votes for the election of the Board of Directors.
|
||
(c)
|
Disclose whether or not a majority of directors are independent. If a majority of directors are not independent, describe what the board of directors does to facilitate its exercise of independent judgment in carrying out its responsibilities.
|
The majority of directors are independent:
From September 1, 2015 to November 1, 2016, 5 out of 6.
|
||
(d)
|
If a director is presently a director of any other issuer that is a reporting issuer (or the equivalent) in a jurisdiction or a foreign jurisdiction, identify both the director and the other issuer.
|
François Côté is presently a member of the board of directors of Lumenpulse Inc., a reporting issuer.
|
||
(e)
|
Disclose whether or not the independent directors hold regularly scheduled meetings at which non-independent directors and members of management are not in attendance. If the independent directors hold such meetings, disclose the number of meetings held since the beginning of the issuer's most recently completed financial year. If the independent directors do not hold such meetings, describe what the board does to facilitate open and candid discussion among its independent directors.
|
The independent Directors hold as many meetings as needed annually and any Director may request a meeting at any time. From September 1, 2015 and to November 1, 2016 five (5) meetings of independent Directors without Management occurred.
In June 2011, an Independent Members Committee Charter was adopted.
|
||
(f)
|
Disclose whether or not the chair of the board is an independent director. If the board has a chair or lead director who is an independent director, disclose the identity of the independent chair or lead director, and describe his or her role and responsibilities. If the board has neither a chair that is independent nor a lead director that is independent, describe what the board does to provide leadership for its independent directors.
|
The Chair of the Board of Directors (being the majority shareholder) is not an independent Director. Since 2002, the Corporation has named an independent director to act as "Lead Director". Mr. Darryl Edwards has been acting as the independent "Lead Director" of the Corporation from January 2013 until January 2016 and Mr. François Côté has been acting as the independent "Lead Director" of the Corporation since January 2016.
The Lead Director is an outside and unrelated Director appointed by the Board of Directors to ensure that the Board of Directors can perform its duties in an effective and efficient manner independent of Management. The appointment of a Lead Director is part of the Corporation's ongoing commitment to good corporate governance. The Lead Director will namely:
|
|||
●
|
provide independent leadership to the Board of Directors;
|
||||
●
|
select topics to be included in the Board of Directors meetings;
|
||||
●
|
facilitate the functioning of the Board of Directors independently of the Corporation's Management;
|
||||
●
|
maintain and enhance the quality of the Corporation's corporate governance practices;
|
||||
●
|
in the absence of the Executive Chair, act as chair of meetings of the Board of Directors;
|
||||
●
|
recommend, where necessary, the holding of special meetings of the Board of Directors;
|
||||
●
|
serve as Board of Directors ombudsman, so as to ensure that questions or comments of individual directors are heard and addressed;
|
||||
●
|
manage and investigate any report received through the Corporation website pursuant to the Corporation's Statement on reporting Ethical Violations, Ethics and Business Conduct Policy and Agent Code of Conduct; and
|
||||
●
|
work with the Board of Directors to facilitate the process for developing, monitoring and evaluating specific annual objectives for the Board of Directors each year.
|
||||
(g) | Disclose the attendance record of each director for all board meetings held since the beginning of the issuer's most recently completed financial year. | The table below indicates the Directors' record of attendance at meetings of the Board of Directors and its committees during the financial year ended August 31, 2016: |
Director
|
Board
Meetings Attended |
Audit Committee
Meetings Attended
|
Human Resources
Committee
Meetings Attended
|
Independent Directors
Meetings Attended
|
Total Board and
Committee Meetings
Attendance Rate
|
||
Lamonde, Germain
|
4 of 4
|
n/a
|
n/a
|
n/a
|
100%
|
||
Allard, Pierre-Paul
|
3 of 4
|
3 of 4
|
3 of 4
|
3 of 4
|
75%
|
||
Côté, François
|
4 of 4
|
4 of 4
|
4 of 4
|
4 of 4
|
100%
|
||
Edwards, Darryl
|
4 of 4
|
3 of 4
|
3 of 4
|
3 of 4
|
81%
|
||
Séguin, Claude
|
4 of 4
|
4 of 4
|
4 of 4
|
4 of 4
|
100%
|
||
Tornes, Randy E.
|
3 of 4
|
4 of 4
|
4 of 4
|
3 of 4
|
88%
|
||
Attendance Rate:
|
92%
|
90%
|
90%
|
85%
|
89%
|
||
2.
|
Board Mandate – Disclose the text of the board's written mandate. If the board does not have a written mandate, describe how the board delineates its role and responsibilities.
|
|||
(a)
|
Assuring the integrity of the executive officers and creating a culture of integrity throughout the organization.
|
The Board of Directors is committed to maintaining the highest standards of integrity throughout the organization. Accordingly, the Board of Directors adopted an Ethics and Business Conduct Policy and a Statement on Reporting Ethical Violations (Whistleblower Policy) which are available on the Corporation's website (www.EXFO.com) to all employees and initially distributed to every new employees of the Corporation.
|
||
(b)
|
Adoption of a strategic planning process.
|
The Board of Directors provides guidance for the development of the strategic planning process and approves the process and the plan developed by Management annually. In addition, the Board of Directors carefully reviews the strategic plan and deals with strategic planning matters that arise during the year.
|
||
(c)
|
Identification of principal risks and implementing of risk management systems.
|
The Board of Directors works with Management to identify the Corporation's principal risks and manages these risks through regular appraisal of Management's practices on an ongoing basis.
|
||
(d)
|
Succession planning including appointing, training and monitoring senior management.
|
The Human Resources Committee is responsible for the elaboration and implementation of a succession planning process and its updates as required. The Human Resources Committee is responsible to monitor and review the performance of the Chief Executive Officer and that of all other senior officers.
|
||
(e)
|
Communications policy.
|
The Chief Financial Officer of the Corporation is responsible for communications between Management and the Corporation's current and potential shareholders and financial analysts. The Board of Directors adopted and implemented Disclosure Guidelines to ensure consistency in the manner that communications with shareholders and the public are managed. The Audit Committee reviews press releases containing the quarterly results of the Corporation prior to release. In addition, all material press releases of the Corporation are reviewed by the President and Chief Executive Officer, Chief Financial Officer, Investor Relations Manager, Director of Financial Reporting and Accounting and General Counsel. The Disclosure Guidelines have been established in accordance with the relevant disclosure requirements under applicable Canadian and United States securities laws.
|
||
(f)
|
Integrity of internal control and management information systems.
|
The Audit Committee has the responsibility to review the Corporation's systems of internal controls regarding finance, accounting, legal compliance and ethical behavior. The Audit Committee meets with the Corporation's external auditors on a quarterly basis. Accordingly, the Corporation fully complies with Sarbanes-Oxley Act requirements within the required period of time.
|
||
(g)
|
Approach to corporate governance including developing a set of corporate governance principles and guidelines that are specifically applicable to the issuer.
|
The Board of Directors assumes direct responsibility for the monitoring of the Board of Director's corporate governance practices, the functioning of the Board of Directors and the powers, mandates and performance of the committees. These responsibilities were previously assumed by the Human Resources Committee. Accordingly, the Board of Directors adopted the following policies to fully comply with these responsibilities, which are updated on a regular basis as required:
|
||||
Policy
|
Adopted
|
Amendments
|
||||
Audit Committee Charter*
|
March 2005
|
November 2011 (French version only)
October 2014
|
||||
Board of Directors Corporate Governance Guidelines*
|
March 2005
|
|||||
Code of Ethics for our Principal Executive Officer and Senior Financial Officers*
|
March 2005
|
|||||
Disclosure Guidelines
|
March 2005
|
May 2005
August 2008
|
||||
Ethics and Business Conduct Policy*
|
March 2005
|
June 2013
|
||||
Human Resources Committee Charter*
|
September 2006
October 2012
January 2013
October 2014
|
|||||
Securities and Trading Policy
|
March 2005
|
|||||
Statement on Reporting Ethical Violations (Whistleblower Policy)*
|
March 2005
|
June 2013
|
||||
Policy Regarding Hiring Employees and Former Employees of Independent Auditors*
|
October 2006
|
|||||
Best Practice Regarding the Granting Date of Stock Incentive Compensation
|
April 2007
|
|||||
Guidelines Regarding the Filing and Disclosure of Material Contracts
|
October 2008
|
|||||
Independent Committee Charter
|
June 2011
|
|||||
Majority Voting Policy*
|
October 2011
|
March 2016
|
||||
Policy Regarding Conflict Minerals*
|
January 2013
|
|||||
Agent Code of Conduct*
|
September 2013
|
|||||
Director Share Ownership Policy*
|
September 2013
|
|||||
* Available on the Corporation's website (www.EXFO.com).
|
||||||
The Board of Directors adopted in October 2011 a Majority Voting Policy for the election of Directors and updated it in accordance with the TSX Rules in March 2016. In October 2012 in order to expressly reflect the responsibility of the Human Resources Committee to conduct an annual assessment of the risks associated with the Corporation's executive compensation policies and procedures, the Board of Directors amended the Human Resources Committee Charter. The Board of Directors amended in January 2013 the Human Resources Committee Charter to include within the Human Resources Committee's mandate the responsibility to receive and discuss suggestions from shareholders for potential director's nominees. Also in January 2013, the Board of Directors adopted a Policy Regarding Conflict Minerals. In the course of formalizing its anti-corruption compliance program, the Board of Directors amended the Ethics and Business Conduct Policy and the Statement on Reporting Ethical Violations (Whistleblower Policy) in June 2013 and also adopted in September 2013 the Agent Code of Conduct. In September 2013, the Board of Directors integrated a governance best practice by adopting a Director Share Ownership Policy.
|
||||||
The Board of Directors amended in October 2014 the Human Resources Committee Charter in order to adapt it to the latest NASDAQ Rules on compensation committees along with an update on the nomination of Directors process and the Audit Committee Charter in order to harmonize its terminology with MI 52-110.
|
||||||
(h)
|
Expectations and responsibilities of Directors, including basic duties and responsibilities with respect to attendance at board meetings and advance review of meeting materials.
|
The Board of Directors is also responsible for the establishment and functioning of all of the Board of Directors' committees, their compensation and their good standing. At regularly scheduled meetings of the Board of Directors, the Directors receive, consider and discuss committee reports. The Directors also receive in advance of any meeting, all documentation required for the upcoming meetings and they are expected to review and consult this documentation.
|
||||
3.
|
Position Descriptions
|
|||||
(a)
|
Disclose whether or not the board has developed written position descriptions for the chair of the board and the chair of each board committee. If the board has not developed written position descriptions for the chair and/or the chair of each board committee, briefly describe how the board delineates the role and responsibilities of each such position.
|
There is no specific mandate for the Board of Directors, however the Board of Directors is, by law, responsible for managing the business and affairs of the Corporation. Any responsibility which is not delegated to senior Management or to a committee of the Board of Directors remains the responsibility of the Board of Directors. Accordingly, the chair of the Board of Directors, of the Audit Committee and of the Human Resources Committee will namely:
|
||||
●
|
provide leadership to the Board of Directors or Committee;
|
|||||
●
|
ensure that the Board of Directors or Committee can perform its duties in an effective and efficient manner;
|
|||||
●
|
facilitate the functionary of the Board of Directors or Committee; and
|
|||||
●
|
promote best practices and high standards of corporate governance.
|
|||||
(b)
|
Disclose whether or not the board and CEO have developed a written position description for the CEO. If the board and CEO have not developed such a position description, briefly describe how the board delineates the role and responsibilities of the CEO.
|
No written position description has been developed for the CEO. The President and Chief Executive Officer, along with the rest of Management placed under his supervision, is responsible for meeting the corporate objectives as determined by the strategic objectives and budget as they are adopted each year by the Board of Directors.
|
||||
4.
|
Orientation and Continuing Education
|
|||||
(a)
|
Briefly describe what measures the board takes to orient new directors regarding
|
|||||
i.
|
the role of the board, its committees and its directors; and
|
The Human Resources Committee Charter foresees that the Human Resources Committee maintains an orientation program for new Directors.
|
||||
ii.
|
the nature and operation of the issuer's business.
|
Presentations and reports relating to the Corporation's business and affairs are provided to new Directors. In addition, new Board of Directors members meet with senior Management of the Corporation to review the business and affairs of the Corporation.
|
||||
(b)
|
Briefly describe what measures, if any, the board takes to provide continuing education for its directors. If the board does not provide continuing education, describe how the board ensures that its directors maintain the skill and knowledge necessary to meet their obligations as directors.
|
The Human Resources Committee Charter foresees that the Human Resources Committee maintains a continuing education program for Directors. In March 2013, the independent Directors of the Corporation attended a presentation on the Corruption of Foreign Public Officials Act given by PricewaterhouseCoopers LLP. In March 2014, the independent Directors of the Corporation attended a presentation on directors' fiduciary duty by Fasken Martineau DuMoulin LLP. In March 2015, the Directors of the Corporation attended a presentation on directors' fiduciary duty in a controlled environment and on Corporate Governance by Norton Rose Fulbright LLP. In October 2015 the Directors of the Corporation attended a presentation on the Corporation's Service Assurance products by the Vice-President Transport and Service Assurance Division of the Corporation. In 2016, the Directors of the Corporation attended an online training on the Corporation's business and orientation.
|
|||
5.
|
Ethical Business Conduct
|
||||
(a)
|
Disclose whether or not the board has adopted a written code for the directors, officers and employees. If the board has adopted a written code:
|
The Corporation is committed to maintaining the highest standard of business conduct and ethics. Accordingly, the Board of Directors updated and established (i) a Board of Directors Corporate Governance Guidelines, (ii) a Code of Ethics for our Principal Executive Officer and senior Financial Officers, (iii) an Ethics and Business Conduct Policy and (iv) a Statement on Reporting Ethical Violations (Whistleblower Policy) which are available on the Corporation's website (www.EXFO.com).
|
|||
i.
|
disclose how a person or company may obtain a copy of the code;
|
||||
ii.
|
describe how the board monitors compliance with its code, or if the board does not monitor compliance, explain whether and how the board satisfies itself regarding compliance with its code; and
|
The Board of Directors will determine, or designate appropriate persons to determine, appropriate actions to be taken in the event of a violation of the Code of Ethics for our Principal Executive Officer and senior Financial Officers. Someone that does not comply with this Code of Ethics will be subject to disciplinary measures, up to and including discharge from the Corporation. Furthermore, a compliance affirmation must be filled in a written form agreeing to abide by the policies of the Code of Ethics.
|
|||
iii.
|
provide a cross-reference to any material change report filed since the beginning of the issuer's most recently completed financial year that pertains to any conduct of a director or executive officer that constitutes a departure from the code.
|
No material change report has been required or filed during our financial year ended August 31, 2016 with respect to any conduct constituting a departure from our Code of Ethics.
|
|||
(b)
|
Describe any steps the board takes to ensure directors exercise independent judgement in considering transactions and agreements in respect of which a director or executive officer has a material interest.
|
Activities that could give rise to conflicts of interest are prohibited. Members of the Board of Directors should contact the Lead Director or in-house legal counsel regarding any issues relating to possible conflict of interest. If such event occurs, the implicated Board of Directors member will not participate in the meeting and discussion with respect to such possible conflict of interest and will not be entitled to vote on such matter. Senior executives should also contact the in-house legal counsel regarding any issues relating to possible conflict of interest.
|
|||
(c)
|
Describe any other steps the board takes to encourage and promote a culture of ethical business conduct.
|
The Corporation has instituted and follows a "Whistleblower Policy" where each member of the Board of Directors as well as any senior officer, every employee of the Corporation and any person is invited and encouraged to report anything appearing or suspected of being non-ethical to our Lead Director, in confidence. The Lead Director has the power to hire professional assistance to conduct an internal investigation should he so fell it is required.
|
||
6.
|
Nomination of Directors
|
|||
(a)
|
Describe the process by which the board identifies new candidates for board nomination.
|
The Board of Directors adopted and implemented a Human Resources Committee Charter which integrates the Compensation Committee Charter and the Nominating and Governance Committee Charter. The Human Resources Committee is responsible for nomination, assessment and compensation of directors and Officers.
More specifically, the Human Resources committee, which is comprised entirely of independent Directors, is responsible for participating in the recruitment and recommendation of new candidates for appointment or election to the Board. When considering a potential candidate, the Human Resources Committee considers the qualities and skills that the Board, as a whole, should have and assesses the competencies and skills of the current members of the Board. Based on the talent already represented on the Board, the Human Resources Committee then identifies the specific skills, personal qualities or experiences that a candidate should possess in light of the opportunities and risks facing the Corporation. Potential candidates are screened to ensure that they possess the requisite qualities, including integrity, business judgment and experience, business or professional expertise, independence from Management, international experience, financial literacy, excellent communications skills and the ability to work well with the Board and the Corporation. The Human Resources Committee considers the existing commitments of a potential candidate to ensure that such candidate will be able to fulfill his or her obligations as a Board member.
The Human Resources Committee maintains a list of potential director candidates for its future consideration and may engage outside advisors to assist in identifying potential candidates. The Human Resources Committee also considers recommendations for director nominees submitted by the Corporation's shareholders, officers, Directors and senior Management.
|
(b)
|
Disclose whether or not the board has a nominating committee composed entirely of independent directors. If the board does not have a nominating committee composed entirely of independent directors, describe what steps the board takes to encourage an objective nomination process.
|
The Human Resources Committee consists of five (5) members all of whom are independent Directors. The Chairman of the Human Resources Committee was Mr. Guy Marier until January 7, 2015. Since then, Mr. François Côté is the Chairman of the Human Resources Committee.
The Human Resources Committee Charter foresees:
|
|||
●
|
recommending a process for assessing the performance of the Board of Directors as a whole, the Chair of the Board of Directors and the Committee chairs and the contribution of individual Directors, and seeing to its implementation;
|
(c)
|
If the board has a nominating committee, describe the responsibilities, powers and operation of the nominating committee.
|
●
|
recommending the competencies, skills and personal qualities required on the Board of Directors in order to create added value, taking into account the opportunities and risks faced by the Corporation and subsequently identifying and recommending to the Board of Directors.
|
||
7.
|
Compensation
|
||||
(a)
|
Describe the process by which the board determines the compensation for the issuer's directors and officers.
|
The Human Resources Committee reviews periodically compensation policies in light of market conditions, industry practice and level of responsibilities. Only independent Directors are compensated for acting as a Director of the Corporation.
|
|||
(b)
|
Disclose whether or not the board has a compensation committee composed entirely of independent directors. If the board does not have a compensation committee composed entirely of independent directors, describe what steps the board takes to ensure an objective process for determining such compensation.
|
The Human Resources Committee consists of five (5) members all of who are independent Directors. The Chairman of the Human Resources Committee was Mr. Guy Marier until January 7, 2015. Since then, Mr. François Côté is the Chairman of the Human Resources Committee.
|
|||
(c)
|
If the board has a compensation committee, describe the responsibilities, powers and operation of the compensation committee.
|
The Human Resources Committee Charter foresees that such committee shall:
|
|||
●
|
review and approve on an annual basis with respect to the annual compensation of all senior officers which namely includes the assessment of risks associated with the compensation of such senior officers;
|
||||
●
|
review and approve, on behalf of the Board of Directors or in collaboration with the Board of Directors as applicable, on the basis of the attribution authorized by the Board of Directors, to whom options to purchase shares of the Corporation, RSUs or DSUs shall be offered as the case may be and if so, the terms of such options, RSUs or DSUs in accordance with the terms of the Corporation's LTIP or the Deferred Share Unit Plan provided that no options, RSUs or DSUs shall be granted to members of this committee without the approval of the Board of Directors;
|
||||
●
|
recommend to the Board of Directors from time to time the remuneration to be paid by the Corporation to Directors;
|
||||
●
|
make recommendations to the Board of Directors with respect to the Corporation's incentive compensation plans and equity-based plans.
|
||||
8.
|
Other Board Committees – If the board has standing committees other than the audit, compensation and nominating committees identify the committees and describe their function.
|
The Board of Directors has no other standing committee.
|
|||
9.
|
Assessments – Disclose whether or not the board, its committees and individual directors are regularly assessed with respect to their effectiveness and contribution. If assessments are regularly conducted, describe the process used for the assessments. If assessments are not regularly conducted, describe how the board satisfies itself that the board, its committees, and its individual directors are performing effectively.
|
The Board of Directors assumes direct responsibility for the monitoring of the Board of Directors' corporate governance practices, the functioning of the Board of Directors and the powers, mandates and performance of the Human Resources Committee. The Human Resources Committee, composed solely of independent Directors, initiates a self-evaluation of the Board of Directors' performance on an annual basis. Questionnaires are distributed to each independent director for the purpose of evaluation the Board of Directors' responsibilities and functions and the performance of the Board of Directors' Committees. The results of the questionnaires are compiled on a confidential basis to encourage full and frank commentary and are discussed at the next regular meeting of the Human Resources Committee or independent Board of Directors members meeting.
|
||
10.
|
Director Term Limits and Other Mechanisms of Board Renewal –
Disclose whether or not the issuer has adopted term limits for the directors on its board or other mechanisms of board renewal and, if so, include a description of those director term limits or other mechanisms of board renewal. If the issuer has not adopted director term limits or other mechanisms of board renewal, disclose why it has not done so.
|
The Corporation does not have a policy that limits the term of the directors on its board. The Board has determined that the term limit of the director's mandate or the mandatory retirement age is not essential in part, because Board renewal has not been a challenge for the Corporation in recent years. Specifically, the average tenure of the current independent directors is low, at approximately four (4) years and a half (fifty-four (54) months). Historically, the average tenure of the independent directors that served on the Board of Directors since 2000 is nine (9) years and four (4) months. In addition, the Corporation seeks to avoid losing the services of a qualified director with experience and in-depth knowledge of the Corporation through the imposition of an arbitrary term limit but is of the opinion however that a balance between long‐term directors and new directors who bring a different experience and new ideas is essential.
The Human Resources Committee initiates a self-evaluation of the Board of Director's performance on an annual basis. This evaluation is an alternative mechanism for renewing the terms of the Directors serving on its Board of Directors. The annual review process of the overall efficiency of the Board of Directors and Committees as a whole and of Committee members and Directors on an individual basis, remains the best way of ensuring that the skills required are well represented within the Board of Directors.
|
||
11.
|
Policies Regarding the Representation of Women on the Board
|
|||
(a)
|
Disclose whether the issuer has adopted a written policy relating to the identification and nomination of women directors. If the issuer has not adopted such a policy, disclose why it has not done so.
|
The Corporation does not have any written policy regarding the identification and nomination of women directors as it did not deem it necessary and its focus is on the recruitment of candidates with the specific skills, personal qualities and experiences to add the highest value to the Board, rather than on the gender or other personal characteristics of particular candidates.
|
||
(b)
|
If an issuer has adopted a policy referred to in (a), disclose the following in respect of the policy:
|
The Corporation does not have a written policy.
|
|||
i.
|
a short summary of its objectives and key provisions,
|
||||
ii.
|
the measures taken to ensure that the policy has been effectively implemented,
|
||||
iii.
|
annual and cumulative progress by the issuer in achieving the objectives of the policy, and
|
||||
iv.
|
whether and, if so, how the board or its nominating committee measures the effectiveness of the policy.
|
||||
12.
|
Consideration of the Representation of Women in the Director Identification and Selection Process – Disclose whether and, if so, how the board or nominating committee considers the level of representation of women on the board in identifying and nominating candidates for election or re-election to the board. If the issuer does not consider the level of representation of women on the board in identifying and nominating candidates for election or re-election to the board, disclose the issuer's reasons for not doing so.
|
The Human Resources Committee does not specifically consider the level of representation of women on the Board in identifying and nominating candidates for election or re-election to the Board. In the context of such process, it considers the then current Board composition and anticipated competencies required so as to add the highest value to the Board. See Heading 6 "Nomination of Directors" on page 125 of this Annual Report for a description of the process adhered to by the Corporation to select director candidates.
|
|||
13.
|
Consideration Given to the Representation of Women in Executive Officer Appointments – Disclose whether and, if so, how the issuer considers the level of representation of women in executive officer positions when making executive officer appointments. If the issuer does not consider the level of representation of women in executive officer positions when making executive officer appointments, disclose the issuer's reasons for not doing so.
|
The Corporation is focused on finding executive talent to grow and expand its business. As such, it focuses on recruiting and retaining executive talent needed to develop and implement the Corporation's strategy, objectives and goals without regard for the gender or other personal characteristics of particular candidates for executive officer positions.
|
|||
14.
|
Issuer's Targets Regarding the Representation of Women on the Board and in Executive Officer Positions
|
||||
(a)
|
For purposes of this Item, a "target" means a number or percentage, or a range of numbers or percentages, adopted by the issuer of women on the issuer's board or in executive officer positions of the issuer by a specific date.
|
||||
(b)
|
Disclose whether the issuer has adopted a target regarding women on the issuer's board. If the issuer has not adopted a target, disclose why it has not done so.
|
The Corporation does not have a target of women on the Board of Directors because it does not believe that any candidate for membership to the Board of Directors should be chosen nor excluded solely or largely because of gender or other personal characteristics. In selecting director nominee, the Corporation considers the skills, expertise and background that would complement the existing Board.
|
|||
(c)
|
Disclose whether the issuer has adopted a target regarding women in executive officer positions of the issuer. If the issuer has not adopted a target, disclose why it has not done so.
|
The Corporation has not adopted a target regarding women in executive officer positions of the Corporation. The Corporation considers candidates based on their qualifications, personal qualities, business background and experience, and does not feel that targets necessarily result in the identification or selection of the best candidates.
|
|||
(d)
|
If the issuer has adopted a target referred to in either (b) or (c), disclose:
|
||||
i.
|
the target, and
|
||||
ii.
|
the annual and cumulative progress of the issuer in achieving the target.
|
||||
15.
|
Number of Women on the Board and in Executive Officer Positions
|
||||
(a)
|
Disclose the number and proportion (in percentage terms) of directors on the issuer's board who are women.
|
Even though the Corporation did have a woman member of the Board in the past, currently, none of the Corporation's Board members are women (0%).
|
|||
(b)
|
Disclose the number and proportion (in percentage terms) of executive officers of the issuer, including all major subsidiaries of the issuer, who are women.
|
Even though the Corporation did have women as executive officers in the past, currently, none of the Corporation's executive officers are women (0%).
|